American National Group Inc
For the period ended Jun 30, 2024. Filed Aug 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 14, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements (unaudited)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2024
- Organization and Description of the Company
American National Group Inc., together with its subsidiaries (collectively, “ANGI”, “we”, “our”, “us”, or the “Company”) is a leading insurance company that offers a broad portfolio of insurance products including individual and group life insurance, annuities, pension risk transfer (“PRT”), health insurance and property and casualty insurance. Business is conducted in 50 states, the District of Columbia and Puerto Rico.
On May 2, 2024, the Company's predecessor, American Equity Investment Life Holding Company, an Iowa corporation ("AEL" or "American Equity") merged with and into Arches Merger Sub Inc. ("Merger Sub"), an indirect wholly-owned subsidiary of Brookfield Reinsurance Ltd. ("Brookfield Reinsurance"), with AEL surviving and becoming an indirect wholly-owned subsidiary of Brookfield Reinsurance (the "Merger"). In connection with the Merger, each issued and outstanding share of AEL's common stock was converted into the right to receive cash and class A limited voting shares of Brookfield Asset Management Ltd. (“BAM”). On May 7, 2024, American National Group, LLC, an indirect, wholly-owned subsidiary of Brookfield Reinsurance ("American National"), merged with and into AEL, with AEL surviving as an indirect, wholly-owned subsidiary of Brookfield Reinsurance (the "Post-Effective Merger"). Subsequently, AEL discontinued its existence as an Iowa corporation and continued its existence as a corporation incorporated in the State of Delaware (the "Reincorporation"). In connection with the Reincorporation, AEL changed its name to American National Group Inc. ANGI is an indirect, wholly-owned subsidiary of Brookfield Reinsurance. For purposes of these notes to the unaudited consolidated financial statements (“financial statements”), the “Company” refers to either ANGI or AEL, as required by the context.
As a result of the Post-Effective Merger, the condensed consolidated financial statements for the periods prior to the Post-Effective Merger represent the results of American National as the accounting acquirer. For periods subsequent to the Post-Effective Merger, the condensed consolidated financial statements represent the combined results of American National and AEL.
- Summary of Significant Accounting Policies
The unaudited consolidated financial statements and notes thereto, including all prior periods presented, have been prepared under accounting principles generally accepted in the United States of America (“GAAP”). The financial statements are prepared on a going concern basis and have been presented in U.S. dollars (“USD”) rounded to the nearest million unless otherwise indicated. The financial statements should be read in conjunction with the December 31, 2023 audited consolidated financial statements of the Company and accompanying notes included in Exhibit 99.1 of the Form 8-K/A, filed with the SEC on July 23, 2024. The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of the results for any subsequent periods or the entire fiscal year ending December 31, 2024. These financial statements reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of results for the interim periods presented in accordance with GAAP.
The preparation of the financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Included among the material (or potentially material) reported amounts and disclosures that require use of estimates are: fair value of certain financial assets including real estate, derivatives, allowances for credit losses, deferred policy acquisition costs (“DAC”), deferred sales inducements (“DSI”), value of business acquired (“VOBA”), goodwill and other intangibles, market risk benefits, future policy benefits (“FPB”), policyholder account balances including the fair value of the embedded derivatives in fixed index annuity contracts, funds withheld liabilities, pension plans, and income taxes including the recoverability of our deferred tax assets. Such estimates and assumptions are subject to inherent uncertainties, which may result in actual amounts differing from reported amounts.
Reclassification of Prior Year Presentation
As a result of the acquisition of AEL and the increase in significance of certain accounts resulting from the consolidation of AEL, certain previously reported amounts have been reclassified to conform to the current financial statement presentation. These reclassifications had no impact on net income (loss) as reported in the statements of operations, as well as total assets, liabilities or equity in the statements of financial position. The following tables and explanatory notes present adjustments within the statement of financial position as of December 31, 2023 and statement of operating results for the three and six months ended June 30, 2023 to conform the presentation to that of ANGI’s.
| American National, Historical | Reclassificationto ConformPresentation | Notes | American National, Conformed | |
|---|---|---|---|---|
| (Dollars in millions) | ||||
| Available-for-sale fixed maturity securities, at fair value | $13,071 | $(194) | 2(b) | $12,877 |
| Private loans | — | 194 | 2(b) | 194 |
| Market risk benefit asset | 34 | (34) | 2(a) | — |
| Current tax receivable | 98 | (98) | 2(a) | — |
| Prepaid pension | 248 | (248) | 2(a) | — |
| Intangible assets | — | 44 | 2(a) | 44 |
| Other assets | 205 | 336 | 2(a) | 541 |
| Liability for retirement benefits | 26 | (26) | 2(c) | — |
| Other liabilities | 441 | 26 | 2(c) | 467 |
| $14,123 | $— | $14,123 | ||
| American National, Historical | Reclassificationto ConformPresentation | Notes | American National, Conformed | |
|---|---|---|---|---|
| (Dollars in millions) | ||||
| Net investment income | $382 | $(40) | 2(f), (j) | $342 |
| Investment related gains (losses) | — | 41 | 2(d) | 41 |
| Net realized investment gains (losses) | (28) | 28 | 2(d) | — |
| Increase in investment credit loss | (2) | 2 | 2(d) | — |
| Net gains (losses) on equity securities | 71 | (71) | 2(d) | — |
| Other income | 13 | (13) | 2(j) | — |
| Policyholder benefits and claims incurred | (972) | (17) | 2(f) | (989) |
| Interest credited to policyholders' account balances | (136) | 136 | 2(f) | — |
| Interest sensitive contract benefits | — | (116) | 2(j) | (116) |
| Amortization of deferred policy acquisition costs, deferred sales inducements, and value of business acquired | — | (132) | 2(g), (i) | (132) |
| Change in fair value of insurance-related derivatives and embedded derivatives | — | 26 | 2(f) | 26 |
| Change in fair value of market risk benefits | (5) | 17 | 2(j) | 12 |
| Commissions for acquiring and servicing policies | (214) | 214 | 2(h) | — |
| Other operating expenses | (191) | 191 | 2(e) | — |
| Operating expenses | — | (148) | 2(e), (g), (h), (i) | (148) |
| Interest expense | — | (22) | 2(e) | (22) |
| Change in deferred policy acquisition | 94 | (94) | 2(i) | — |
| Other components of net periodic pension benefit (costs), net of tax | 2 | (2) | 2(j) | — |
| $(986) | $— | $(986) | ||
| American National, Historical | Reclassificationto ConformPresentation | Notes | American National, Conformed | |
| (Dollars in millions) | ||||
| Net investment income | $723 | $(57) | 2(f), (j) | $666 |
| Investment related gains (losses) | — | (20) | 2(d) | (20) |
| Net realized investment gains (losses) | (50) | 50 | 2(d) | — |
| Increase in investment credit loss | (13) | 13 | 2(d) | — |
| Net gains (losses) on equity securities | 43 | (43) | 2(d) | — |
| Other income | 21 | (21) | 2(j) | — |
| Policyholder benefits and claims incurred | (1,691) | 2 | 2(f) | (1,689) |
| Interest credited to policyholders' account balances | (276) | 276 | 2(f) | — |
| Interest sensitive contract benefits | — | (205) | 2(j) | (205) |
| Amortization of deferred policy acquisition costs, deferred sales inducements, and value of business acquired | — | (263) | 2(g), (i) | (263) |
| Change in fair value of insurance-related derivatives and embedded derivatives | — | — | 2(f) | — |
| Change in fair value of market risk benefits | 8 | (1) | 2(j) | 7 |
| Future policy benefit remeasurement losses | 1 | (1) | 2(j) | — |
| Commissions for acquiring and servicing policies | (393) | 393 | 2(h) | — |
| Other operating expenses | (369) | 369 | 2(e) | — |
| Operating expenses | — | (303) | 2(e), (g), (h), (i) | (303) |
| Interest expense | — | (46) | 2(e) | (46) |
| Change in deferred policy acquisition | 142 | (142) | 2(i) | — |
| Other components of net periodic pension benefit (costs), net of tax | 1 | (1) | 2(j) | — |
| $(1,853) | $— | $(1,853) | ||
The historical financial statements of American National were prepared in accordance with U.S. GAAP. The following adjustments have been made to conform the presentation of the historical financial statements of American National to the presentation of ANGI’s financial statements:
(a)“Other assets” is adjusted to include market risk benefits asset, current tax receivable, and prepaid pension. “Intangible assets” have been presented as a separate line item;
(b)The balance related to “Private loans” has been presented as a separate line item;
(c)“Liability for retirement benefits” is reclassified to “Other liabilities”;
(d)Net realized investment gains (losses), increase in investment credit loss, and net gains (losses) on equity securities have been reclassified to “Investment related gains (losses)”;
(e)Other operating expenses have been bifurcated into “Operating expenses” and “Interest expense”;
(f)Mark-to-market gains on equity-indexed call options and embedded derivatives within Policyholders’ Account Balances are reclassified from “Net investment income” and “Interest credited to policyholders’ account balances”, respectively, to “Change in fair value of insurance-related derivatives and embedded derivatives”;
(g)Capitalization of deferred policy acquisition costs, deferred sales inducements and value of business acquired has been reclassified to “Operating expenses”. “Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired” will only include the amortization expense;
(h)“Commissions for acquiring and servicing policies” is reclassified to “Operating expenses”;
(i)Capitalizations of deferred policy acquisition costs are reclassified from “Change in deferred policy acquisition costs” to “Operating expenses”. Amortization of deferred policy acquisition costs is reclassified from “Change in deferred policy acquisition costs” to “Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired”; and
(j)Other reclassifications.
Basis of Consolidation
These financial statements include the accounts of the Company and its consolidated subsidiaries, which are legal entities where the Company has a controlling financial interest by either holding a majority voting interest or as the primary beneficiary of the variable interest entity (“VIE”). All intra-group transactions, balances, income and expenses are eliminated in full on consolidation.
For a legal entity in which the Company holds a variable interest, the Company first considers whether it meets the definition of a VIE and therefore should apply the guidance under the VIE model. An entity is a VIE if any one of the following conditions exist: (a) the total equity investment at risk is not sufficient for the legal entity to finance its activities without additional subordinated financial support; (b) the holders of the equity investment at risk as a group lack either the power to direct the most significant activities of the entity, the obligation to absorb the expected losses, or the right to receive the expected residual returns; or (c) the entity is structured with non-substantive voting rights, where the voting rights of some investors are disproportionate to their obligation to absorb the expected losses of the legal entity, their rights to receive the expected residual returns of the legal entity, or both and substantially all of the entity’s activities either involve or are conducted on behalf of the investor with disproportionately few voting rights.
The Company consolidates all VIEs for which it is the primary beneficiary, which is the case when the Company has both (a) the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance and (b) the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.
Entities that are determined not to be VIEs are voting interest entities (“VOEs”), which are evaluated under the voting interest model, under which a controlling financial interest is established through a majority voting interest or through other means.
The consolidation assessment, including the determination as to whether an entity qualifies as a VIE or VOE, depends on the specific facts and circumstances for each entity and requires judgment.
Business combinations are accounted for using the acquisition method. The purchase consideration of a business acquisition is measured at the aggregate of the fair values at the date of exchange of assets transferred, liabilities incurred, and equity instruments issued in exchange for control of the acquiree. The acquiree’s identifiable assets, liabilities and contingent liabilities are recognized at their fair values at the acquisition date. The interest of non-controlling shareholders in the acquiree, if applicable, is initially measured at the non-controlling shareholders’ proportion of the net fair value of the identifiable assets, liabilities and contingent liabilities recognized.
To the extent the fair value of consideration paid exceeds the fair value of the net identifiable tangible and intangible assets, the excess is recorded as goodwill.
Transaction costs are recorded as operating expenses on the Consolidated Statements of Operations.
Available-for-sale fixed maturity securities primarily include bonds, asset backed securities and private debt securities. Available-for-sale fixed maturity securities, which may be sold prior to their contractual maturity, are classified as available-for-sale and are carried at fair value with changes in fair value recognized in other comprehensive income, except for those that are designated as hedged items in a fair value hedge, for which changes in fair value are recognized during the period of the hedge in “Investment related gains (losses)” within the Consolidated Statements of Operations.
For available-for-sale fixed maturity securities in an unrealized loss position, the Company first assesses whether it intends to sell the security or will be required to sell the security before recovery of its amortized cost basis. If either of these criteria are met, the security’s amortized cost basis is written down to fair value through income in “Investment related gains (losses)” within the Consolidated Statements of Operations. Refer to Credit Loss Allowances within this note for impairment or credit loss-related considerations.
Equity securities primarily include common stock, preferred stock and private equity. Equity securities are carried at fair value with changes in fair value recognized in “Investment related gains (losses)” within the Consolidated Statements of Operations, except for certain of private equity, which are carried at cost less impairment, if any, due to the lack of their readily determinable fair values.
Mortgage loans and private loans are both measured at amortized cost using the effective interest rate method. The amortized cost basis includes the unamortized principal, interest, discounts or premiums and deferred expenses, net of allowances for expected credit loss. Interest income, prepayment fees, and amortization of premiums and discounts and origination fees are reported in “Net investment income” in the Consolidated Statements of Operations. However, interest ceases to accrue for loans that are impaired or in default, which is when payments are more than 90 days past due, when collection is not probable, or when a loan is in foreclosure. When a loan is placed on non-accrual status, uncollected past due accrued interest income that is considered uncollectible is charged off against net investment income. Income on impaired loans is reported on a cash basis. When collection of the impaired loan becomes probable again, it is placed back into accrual status. Cash receipts on impaired loans are recorded as a reduction of principal, interest income, expense reimbursement, or other manner in accordance with the loan agreement. In the Consolidated Statements of Operations, gains and losses from the sale of loans and changes in allowances are reported in “Investment related gains (losses)” within the Consolidated Statements of Operations.
Mortgage loans and private loans are both presented net of the Company’s recorded allowance for expected credit loss, which represents the portion of amortized cost basis that the Company does not expect to collect. Refer to Credit Loss Allowances within this note.
Policy loans are carried at the outstanding balance plus any accrued interest. Due to the collateralized nature of policy loans such that they cannot be separated from the policy contracts, the unpredictable timing of repayments and the fact that settlement is at outstanding value, the carrying value of policy loans approximates fair value.
Real estate and real estate partnerships comprise investment real estate, as well as real estate joint ventures and other limited partnerships.
Certain investment real estate, including related improvements and investment real estate held through consolidation of VIEs, are stated at cost less accumulated depreciation. Depreciation is calculated on a straight-line basis over the estimated useful life of the asset (typically 15 to 50 years). Rental income is recognized on a straight-line basis over the term of the respective lease in “Net investment income” within the Consolidated Statements of Operations.
The Company periodically reviews its investment real estate held at depreciated cost for impairment and tests properties for recoverability whenever events or changes in circumstances indicate the carrying amount of the asset may not be recoverable and the carrying value of the property exceeds its estimated fair value. Properties whose carrying values are greater than their undiscounted cash flows are written down to their estimated fair value, with the impairment loss included as an adjustment to “Investment related gains (losses)” in the Consolidated Statements of Operations. Impairment losses are based upon the estimated fair value of real estate, which is generally computed using the present value of expected future cash flows from the real estate discounted at a rate commensurate with the underlying risks as well as other appraisal methods. Real estate acquired upon foreclosure is recorded at the lower of its cost or its estimated fair value at the date of foreclosure.
The Company classifies a property as held-for-sale if it commits to a plan to sell a property within one year and actively markets the property in its current condition for a price that is reasonable in comparison to its estimated fair value. Real estate held-for-sale is stated at the lower of depreciated cost or estimated fair value less expected disposition costs and is not depreciated while it is classified as held-for-sale.
The Company holds certain residential investment real estate through consolidation of investment company VIEs, which are reported at fair value with the change in fair value on these investments reported in “Net investment income” within the statement of operations. Fair values of residential investment real estate are initially based on the cost to purchase the properties and subsequently determined using broker price opinions. The residential investment real estate are leased to renters through operating lease arrangements. Rental income is recognized on a straight-line basis over the term of the respective leases in “Net investment income” within the statement of operations.
Real estate joint ventures and other limited partnership interests include VIEs for which the Company has significant influence over the investee’s operations without a controlling financial interest, and are accounted for using the equity method of accounting. For certain joint ventures or limited partnerships, the Company records its share of earnings using a lag methodology of one to three months when timely financial information is not available, and the contractual right does not exist to receive such financial information. Certain real estate limited partnership interests are carried at cost less impairment, if any.
The Company routinely evaluates its investments in those investees for impairment. The Company considers financial and other information provided by the investee, other known information, and inherent risks in the underlying investments, as well as future capital commitments, in determining whether impairment has occurred. When an impairment is deemed to have occurred at the joint venture level, the Company recognizes its share as an adjustment to “Net investment income” to record the investment at its fair value. When an impairment results from the Company’s separate analysis, an adjustment is made through “Investment related gains (losses)” to record the investment at its fair value.
Certain real estate joint ventures and other limited partnership interests are consolidated VIEs for which the underlying joint ventures are investment companies within scope of ASC Topic 946. These investments are fair valued on a recurring basis with the change in fair value reported in “Net investment income”. Fair values are calculated based on a discounted cash flow methodology.
Investment funds comprise certain non-fixed income, alternative investments in the form of limited partnerships or similar legal structures for which the Company is not the primary beneficiary and therefore is not required to consolidate. The Company typically accounts for investment funds using the equity method of accounting, where the cost is recorded as an investment in the fund upon initial recognition, unless fair value option is elected. Under equity method, adjustments to the carrying amount reflect the Company’s pro rata ownership percentage of the operating results as indicated by net asset value (“NAV”) in the investment fund financial statements, which can be on a lag of up to three months when investee information is not received in a timely manner.
The Company has concluded that we are the primary beneficiary for certain investments funds, which are investment company funds in scope of ASC Topic 946, and consolidate the underlying funds. Valuation methods include NAV as a practical expedient and discounted cash flow models. Income is reported on a quarter lag due to the availability of the related financial statements of the investment funds.
Short-term investments include highly liquid securities and other investments with original maturities of over 90 days and less than one year at the date of acquisition. Securities included within short-term investments are stated at fair value with amortized cost used as an approximation of fair value for certain investments.
Other invested assets primarily comprise derivatives instruments. Derivative instruments are carried at fair value. Derivative instruments include call options used to fund fixed indexed annuity contracts and equity-indexed universal life contracts (“insurance-related derivatives”). Derivative instruments are recorded at fair value on the acquisition date and subsequently revalued at fair value at each reporting date. Derivative instruments with positive values are recorded as derivative assets within “Other invested assets”. If a derivative is not designated for hedge accounting, changes in the fair value of derivatives are recorded in “Investment related gains (losses)” in the Consolidated Statements of Operations, except for insurance-related derivatives, whose fair value changes are recorded in “Change in fair value of insurance-related derivatives and embedded derivatives”, along with fair value changes from embedded derivatives on related fixed indexed annuity contracts.
Where the Company has a master netting agreement with its counterparty that allows for the netting of the Company’s derivative asset and liability positions, the Company elects to offset such derivative assets and liabilities and present them on a net basis on the Consolidated Statements of Financial Position. Further, in some instances, the Company holds collateral to offset exposure from its counterparties relating to its derivative instruments. The Company elects to offset collateral supporting credit risk that is restricted to the Company’s use for the derivative exposure when a master netting arrangement is in place and all offsetting criteria are met.
Federal Home Loan Bank stock, as well as separately managed accounts which are portfolios of individual securities, such as stocks or bonds, that are managed on behalf of the Company by an investment manager, are also included in other invested assets and are carried at cost or market value if available from the account manager. Other invested assets also include Company owned life insurance, tax credit partnerships and mineral rights less allowance for depletion, where applicable.
Reinsurance recoverable and deposit assets include the reinsurance receivables from reinsurers, reinsurance recoverables from reinsurers, and deposit assets associated with reinsurance agreements.
In the normal course of business, the Company is a user of reinsurance in order to limit the potential for losses arising from certain exposures. To the extent that third party reinsurers are unable to meet their obligations, the Company remains liable to its policyholders for the portion reinsured.
For long term duration contracts, we assess each reinsurance agreement to determine whether the agreement transfers significant insurance risk to the reinsurer. If insurance risk is transferred, the Company utilizes the reinsurance method of accounting. If the agreement does not transfer significant insurance risk, the Company utilizes the deposit method of accounting. The reinsurance recoverable and deposit assets include deposit assets, reinsurance market risk benefits, amounts due from reinsurers for paid or unpaid claims, claims incurred but not reported (“IBNR”), policyholder account balances or policy benefits. The reinsurance recoverable is presented net of a reserve for collectability. The Company cedes disability, medical and long-term care insurance, annuity contracts including lifetime income benefit riders, as well as PRT contracts with significant insurance risk to other insurance companies through reinsurance. The Company also cedes annuity contracts without significant insurance risk to other insurance companies.
For short term duration contracts, reinsurance recoverables are the estimated amount due to the Company from reinsurers related to paid and unpaid ceded claims and claim adjustment expenses (“CAE”) and are presented net of a reserve for collectability. Recoveries of gross ultimate losses under the non-catastrophe reinsurance are estimated by a review of individual large claims and the ceded portion of IBNR claims using assumed distribution of loss by percentage retained. Recoveries of gross ultimate losses under our catastrophe reinsurance are estimated by applying reinsurance treaty terms to estimates of gross ultimate losses. The most significant assumption is the average size of the individual losses for those claims that have occurred but have not yet been reported and the estimate of gross ultimate losses. The ultimate amount of the reinsurance ceded recoverable is unknown until all losses settle.
Reinsurance receivables include amounts receivable from third party reinsurers. The reinsurance receivables which will be settled within a year are short-term in nature, and their fair values approximate carrying value. Reinsurance receivables include future installment payments for ceding commissions on reinsured annuity contracts. The receivable is recorded at the net present value of the installment payments.
Credit Loss Allowances and Impairments
Available-for-sale Fixed Maturity Securities
For available-for-sale fixed maturity securities in an unrealized loss position, if the Company does not intend to sell the security or will not be required to sell the securities before recovery of its amortized cost basis, the Company evaluates whether the decline in fair value has resulted from credit loss or market factors.
In making this assessment, management first calculates the extent to which fair value is less than amortized cost, consider any changes to the rating of the security by a rating agency, and any specific conditions related to the security. If this qualitative assessment indicates that a credit loss may exist, and management does not anticipate recovery of all contractual or expected cash flows, the present value of projected future cash flows expected to be collected is compared to the amortized cost basis of the security. The net present value of the expected cash flows is calculated by discounting management’s best estimate of expected cash flows at the effective interest rate implicit in the available-for-sale fixed maturity security when acquired.
If the present value of expected cash flows is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded through income in “Investment related gains (losses)” limited to the amount fair value is less than amortized cost. If the fair value is less than the net present value of its expected cash flows at the impairment measurement date, a non-credit loss exists which is recorded in other comprehensive income (loss) for the difference between the fair value and the net present value of the expected cash flows.
Expected Credit Losses
The Company records an allowance for credit loss in earnings within “Investment related gains (losses)” in an amount that represents the portion of the amortized cost basis of mortgage and private loans that the Company does not expect to collect, resulting in the loans being presented at the net amount expected to be collected. In determining the Company’s credit loss allowances, management applies significant judgment to estimate expected lifetime credit loss, including: (i) pooling loans that share similar risk characteristics, (ii) considering expected lifetime credit loss over the contractual term of its loans adjusted for expected prepayments and any extensions, and (iii) considering past events and current and forecasted economic conditions. The allowance is calculated quarterly for each loan type based on its unique inputs. The Company uses the discounted cash flow model to assess expected credit loss.
Mortgage loans – On an ongoing basis, mortgage loans with dissimilar risk characteristics (i.e., loans with significant declines in credit quality) and collateral dependent mortgage loans (i.e., when the borrower is experiencing financial difficulty, including when foreclosure is probable) may be evaluated individually for credit loss. The valuation allowances for each of our mortgage loan portfolios are estimated by deriving probability of default and recovery rate assumptions based on the characteristics of the loans in each portfolio, historical economic data and loss information, and current and forecasted economic conditions. Key loan characteristics impacting the estimate for our commercial mortgage loan portfolio include the current state of the borrower’s credit quality, which considers factors such as loan-to-value and debt service coverage ratios, loan performance, underlying collateral type, delinquency status, time to maturity, and original credit scores. Key loan characteristics impacting the estimate for our agricultural and residential mortgage loan portfolios include the current state of the borrowers' credit quality, delinquency status, time to maturity and original credit scores.
The allowance for a collateral dependent loan, which is typically a mortgage loan, is established as the excess of amortized cost over the estimated fair value of the loan’s underlying collateral, less selling cost when foreclosure is reasonably possible or probable. Accordingly, the change in the estimated fair value of collateral dependent loans is recorded as a change in the allowance for credit losses which is recorded on a quarterly basis as a charge or credit to earnings.
The Company’s mortgage loans are primarily originated and are not purchased in the secondary market; as such, the mortgage loans would not generally be subject to purchased credit deteriorated considerations. However, for any purchased mortgage loans, the Company performs an analysis that includes both qualitative and quantitative considerations to determine whether any purchases have had more-than-insignificant credit deterioration since origination.
Private loans – For private loans, credit loss allowances are estimates of expected credit losses, established for loans upon origination or purchase, considering all relevant information available, including past events, current conditions, and reasonable and supportable forecasts over the life of the loans. The estimates of expected credit losses are developed using a quantitative probability of default and loss given default methodology, in which default assumptions reflect applicable agency credit ratings or, when such external credit ratings are not available, internally developed ratings. Loans are evaluated on a pooled basis when they share similar risk characteristics; otherwise, they are evaluated individually.
Reinsurance recoverables – In the event that reinsurers do not meet their obligations to the Company under the terms of the reinsurance agreements, or when events or changes in circumstances indicate that its carrying amount may not be recoverable, reinsurance recoverable balances could become uncollectible. In such instances, reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance, consistent with credit loss guidance which requires recording an allowance for credit loss.
Premiums receivable – Premiums receivable are included in “Other assets” in the Consolidated Statements of Financial Position and are stated net of allowances for uncollectible premiums, including expected lifetime credit losses, both dispute and credit related. The allowance is based upon our ongoing review of amounts outstanding, historical loss data, including delinquencies and write-offs, current and forecasted economic conditions and other relevant factors. Credit risk is partially mitigated by our ability to cancel the policy if the policyholder does not pay the premium.
Accrued investment income is presented separately on the Consolidated Statements of Financial Position and excluded from the carrying value of the related investments, primarily available-for-sale fixed maturity securities and mortgage loans. The Company has made an accounting policy election not to measure an allowance for credit losses for accrued interest receivable on amortized cost investments and to directly write off the uncollectible balance.
Cash and cash equivalents have durations that do not exceed 90 days at the date of acquisition, include cash on-hand and in banks, as well as amounts invested in money market funds, and are reported as “Cash and cash equivalents” in the Consolidated Statements of Financial Position.
Property and equipment are measured at cost less accumulated depreciation and accumulated impairment losses, if any. Cost includes expenditures that are directly attributable to the acquisition of the asset. The costs of assets include the cost of materials and direct labor, any other costs directly attributable to bringing the assets to a working condition for their intended use, and the cost of dismantling and removing the items and restoring the site on which they are located.
Depreciation of property and equipment commences when it is available for use. Property and equipment are depreciated on a straight-line basis over the estimated useful lives of each component of the property and equipment. The estimated useful lives of the property and equipment arethree tothirty years.
Leasehold improvements are depreciated over the period of the lease or estimated useful life, whichever is the shorter, on a straight-line basis. The right-of-use asset is depreciated on the straight-line basis over the lease term. The estimated useful lives, residual values and depreciation methods are reviewed at the end of each annual reporting period, with the effect of any changes recognized on a prospective basis.
The Company reviews its property and equipment for impairment at least annually and whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.
Intangible assets include definite-lived intangible assets which are carried at cost less accumulated amortization and indefinite-lived intangible assets not subject to amortization, carried at cost. Amortization expense is primarily calculated using the straight-line amortization method.
The Company assesses the impairment of definite-lived intangible assets in accordance with its policy for the impairment of property and equipment. The Company assesses the impairment of indefinite-lived intangible assets in accordance with its policy for the impairment of goodwill.
The Company’s intangible assets are primarily from the acquisition of AEL and American National. Definite-lived intangible assets include distributor relationships and trade names. Indefinite-lived intangible assets represent insurance licenses held by the acquired insurance companies.
(i)Distributor Relationships
The distribution assets reflect relationships AEL and American National have with their respective third-party intermediaries that generate new business for the Company. These assets were valued using the multi-period excess-earnings method, which derives value based on the present value of the after-tax cash flows attributable to the intangible asset only. The useful life of distributor relationships is approximately 15 to 30 years.
(ii)Trade Names
This represents trade names of AEL and American National and was valued using the relief from royalty method, which derives value based on present value of the after-tax royalty savings attributable to owning the intangible asset. The useful life of the trade name is 10 years for AEL and 10 years for American National.
(iii)Insurance Licenses
Given the highly regulated nature of the insurance industry, companies are required to hold certain licenses to operate. These licenses are valued using the comparable transaction method based on observable license transactions in the insurance industry. Insurance licenses represent an indefinite-lived intangible asset.
Deferred policy acquisition costs (“DAC”) and Deferred sales inducements (“DSI”) are capitalized costs related directly to the successful acquisition of new or renewal insurance contracts. Significant costs are incurred to successfully acquire insurance, reinsurance, and annuity contracts, including commissions and certain underwriting, premium bonus, policy issuance, and processing expenses.
Insurance contracts are grouped into cohorts by contract type and issue year consistent with estimating the associated liability for future policy benefits. DAC and DSI are amortized on constant level basis for the grouped contracts over the expected term of the related contracts to approximate straight-line amortization. DAC and DSI will be amortized over the bases selected by product, all of which provide a constant level representation of contract term.
| Product(s) | Amortization Base |
|---|---|
| Traditional life products | Nominal face amount |
| Life contingent payout annuities | Annualized benefit amount in force |
| Health products | Original annual premium |
| Fixed deferred annuities, fixed index annuities, variable annuities | Policy count |
| Universal life products | Initial face amount |
| Property and Casualty | Earned premium |
The assumptions used in the calculation of DAC and DSI include full surrenders, partial withdrawals, mortality, utilization, premium persistency, reset assumptions associated with lifetime income benefit riders, and the option budget assumption. The Company reviews and updates actuarial experience assumptions serving as inputs to the models that establish the expected life for DAC and other actuarial balances during the third quarter of each year, or more frequently if evidence suggests assumptions should be revised. The Company makes model refinements as necessary, and any changes resulting from these assumption updates are applied prospectively.
Amortization of DAC and DSI is included in the “Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired” on the statement of operations.
For short-duration contracts, DAC is grouped consistent with the manner in which insurance contracts are acquired, serviced, and measured for profitability and is reviewed for recoverability based on the profitability of the underlying insurance contracts. Investment income is anticipated in assessing the recoverability of DAC for short-duration contracts.
Value of business acquired (“VOBA”)is an intangible asset or liability resulting from a business combination that represents the difference between the policyholder liabilities measured in accordance with the acquiring company’s accounting policies and the estimated fair value of the same acquired policyholder liabilities in-force at the acquisition date. VOBA can be either positive or negative. Positive VOBA is recorded as a component of DAC in the Consolidated Statements of Financial Position. Negative VOBA occurs when the estimated fair value of in-force contracts in a life insurance company acquisition is less than the amount recorded as insurance contract liabilities, and is recorded in the “Future policy benefits” in the Consolidated Statements of Financial Position.
VOBA is amortized on a straight-line basis over the remaining life of the underlying policies.
Goodwill represents the excess of amounts paid for acquiring businesses over the fair value of the net assets acquired, less any impairment recognized.
Goodwill is not amortized but is tested for impairment at least annually by first assessing whether there are events or changes in circumstances, such as deteriorating or adverse market conditions, indicating that it is more likely than not that the carrying amount of the reporting unit including goodwill may exceed the fair value. If this qualitative assessment indicates that an impairment may exist, a quantitative impairment assessment is then performed and impairment is measured and recognized as the amount by which a reporting unit's carrying value, including goodwill, exceeds its fair value, limited to the carrying amount of goodwill of the reporting unit.
The Company performed its annual goodwill impairment tests as of October 1, 2023 and didnot identify any impairment.
Separate account assets and liabilities are funds that are held separate from the general assets and liabilities of the Company. Separate account assets include funds representing the investments of variable insurance product contract holders, who bear the investment risk of such funds. Investment income and investment gains and losses from these separate funds accrue to the benefit of the contract holders. The Company reports separately, as assets and liabilities, investments held in such separate accounts and liabilities of the separate accounts if (i) such separate accounts are legally recognized; (ii) assets supporting the contract liabilities are legally insulated from the Company’s general account liabilities; (iii) investments are directed by the contract holder; and (iv) all investment performance, net of contract fees and assessments, is passed through to the contract holder. In addition, the Company’s qualified pension plan assets are included in separate accounts. The assets of these accounts are carried at fair value. Deposits, net investment income and realized investment gains and losses for these accounts are excluded from revenues, and related liability increases are excluded from benefits and expenses in the Consolidated Statements of Operations. Separate accounts are established in conformity with insurance laws and are not chargeable with liabilities that arise from any other business of the Company.
Assets received or pledged as collateral – The Company receives and pledges collateral in respect to certain derivative contracts, in order to meet its contractual obligations. The amount of collateral required is determined by the valuation of each contract on a mark-to-market basis and the type of collateral to be deposited is specified within the agreement with each counterparty.
Collateral pledged continues to be recognized in the Consolidated Statements of Financial Position as the Company retains all rights related to these assets.
Collateral received is not recognized in the Consolidated Statements of Financial Position unless the Company acquires the rights relating to the economic risks and rewards related to these assets.
Future policy benefits (“FPB”) is calculated as the present value of expected future policy benefits to be paid or on behalf of policyholders and certain related expenses, reduced by the present value of expected net premiums to be collected from policyholders. Principal assumptions used in the establishment of the FPB include mortality, morbidity, lapse, incidence, terminations, claim-related expenses and other contingent events based on the respective product type. The Company groups contracts into annual cohorts based on product type and contract inception date for the purposes of calculating the liability for future policy benefits.
The Company updates its estimate of cash flows over the entire life of a group of contracts using actual historical experience and current future cash flow assumptions. The Company reviews and updates cash flow assumptions at least annually, and at the same time every year by cohort or product. The Company also reviews more frequently and updates its cash flow assumptions during an interim period if evidence suggests cash flow assumptions should be revised. Assumption revisions will be reflected in the net premium ratio and FPB calculation in the quarter in which assumptions are revised. The effects of changes in such estimated liabilities are included in the Consolidated Statements of Operations in the period in which the changes occur. The change in the liability due to actual experience is recognized in “Policyholder benefits and claims incurred” in the Consolidated Statements of Operations.
The change in FPB that is recognized in “Policyholder benefits and claims incurred” in the statement of operations is calculated using a locked-in discount rate. The Company measures the FPB at each reporting period using both the locked-in discount rate and the current discount rate curves. For contracts issued subsequent to the transition date of Targeted Improvements to the Accounting for Long-Duration Insurance Contracts (“LDTI”), the upper-medium grade discount rate used for interest accretion is locked in for the cohort and represents the original discount rate at the issue date of the underlying contracts. The FPB for all cohorts is remeasured to a current upper-medium grade discount rate at each reporting date through other comprehensive income. The Company generally interprets the original discount rate to be a rate comparable to that of a U.S. corporate single A rate that reflects the duration characteristics of the liability. The upper-medium grade discount rate is determined using observable market data, including published upper-medium grade discount curves. In situations where market data for an upper-medium grade discount curve is not available (e.g., in certain foreign jurisdictions), spreads are applied to adjust the available observable market data to an upper-medium grade discount curve. For certain long-tailed life insurance liabilities with expected future cash flows longer than the last observable tenor (30 years), the discount rate for future cash flows beyond 30 years will be held constant at the ultimate (30 years) observable forward rate.
Should the present value of actual and future expected benefits less day one FPB balance exceed the present value of actual and future expected gross premiums, the net premium ratio will be capped at 100% and a gross premium FPB will be held. The immediate charge will be the amount by which the uncapped net premium ratio exceeds 100% times the present value of future expected gross premium. This assessment will be performed at the cohort level.
Deferred Profit Liability (“DPL”)
For limited-payment products, gross premiums received in excess of net premiums are deferred at initial recognition as a DPL. Gross premiums are measured using assumptions consistent with those used in the measurement of the liability for future policy benefits, including discount rate, mortality, lapses and expenses.
The DPL is amortized and recognized as “Policyholder benefits and claims incurred” in the Consolidated Statements of Operations in proportion to expected future benefit payments from annuity contracts. Interest is accreted on the balance of the DPL using the discount rate determined at contract issuance. The Company reviews and updates its estimate of cash flows from the DPL at the same time as the estimates of cash flows for the liability for future policy benefits. When cash flows are updated, the updated estimates are used to recalculate the DPL at contract issuance. The recalculated DPL as of the beginning of the current reporting period is compared to the carrying amount of the DPL as of the beginning of the current reporting period, and any difference is recognized as “Policyholder benefits and claims incurred” in the Consolidated Statements of Operations.
DPL is recorded in future policy benefits and included as a reconciling item within the disaggregated rollforwards.
Policyholders’ account balances (“PAB”) represent the contract value that has accrued to the benefit of the policyholders related to universal-life and investments-type contracts. For fixed products, these are generally equal to the accumulated deposits plus interest credited, reduced by withdrawals, payouts and accumulated policyholder assessments. Indexed product account balances with returns linked to the performance of a specified market index are equal to the sum of the fair value of the embedded derivatives and the host (or guaranteed) component of the contracts. The host value is established at inception of the contract and accreted over the policy’s life at a constant level of interest. Changes in the fair value of the embedded derivatives are included in the “Change in fair value of insurance-related derivatives and embedded derivatives” in the Consolidated Statements of Operations.
Liabilities for unpaid claims and claim adjustment expenses (“CAE”)are established to provide for the estimated costs of paying claims. These reserves include estimates for both case reserves and IBNR liabilities. Case reserves include the liability for reported but unpaid claims. IBNR liabilities include a provision for potential development on case reserves, losses on claims currently closed which may reopen in the future, as well as IBNR claims. These liabilities also include an estimate of the expense associated with settling claims, including legal and other fees, and the general expenses of administering the claims adjustment process. Liabilities for unpaid claims and claim adjustment expenses for health and property and casualty insurance are included in “Policy and contract claims” in the Consolidated Statements of Financial Position.
Market risk benefits (“MRB”), are contracts or contract features that provide protection to the policyholder from other-than-nominal capital market risk and expose the Company to other-than-nominal capital market risk. The Company issues certain fixed indexed annuity and fixed rate annuity contracts that provide minimum guarantees to policyholders including guaranteed minimum withdrawal benefits and guaranteed minimum death benefits that are MRBs.
MRBs are measured at fair value, at the individual contract level, and can be either an asset or a liability. Contracts which contain more than one MRB feature are combined into one single MRB. The fair value is calculated using stochastic models. At contract inception, attributed fees are calculated based on the present value of the fees and assessments collectible from the policyholder relative to the present value of expected benefits paid attributable to the MRB. The attributed fees remain static over the life of the MRB and is used to calculate the fair value of the MRB using a risk neutral valuation method. The attributed fees cannot be negative and cannot exceed the total explicit fees collectible from the policyholder. The periodic change in fair value is recognized in earnings with the exception of the periodic change in fair value related to the instrument-specific credit risk, which is recognized in other comprehensive income.
The actuarial assumptions used in the MRB calculation are the Company’s best estimate assumptions. Assumptions are adjusted to reflect fair value by applying a margin for non-hedgeable risk and an adjustment for own credit spread through the discount rate. The risk-free discount rate is the scenario specific US treasury rate.
Market risk benefits with positive values are recorded as “Other assets” and negative fair values are reported as “Market risk benefit” liabilities in the Consolidated Statements of Financial Position. The ceded MRB assets are presented in “Reinsurance recoverable and deposit assets” on the Consolidated Balances Sheets.
Funds withheld liabilities represent the payable for amounts contractually withheld in accordance with reinsurance agreements where certain of the Company’s subsidiaries act as cedants. While the assets in the funds withheld are legally owned by the cedant, the reinsurer is subject to all investment performance and economic rights and obligations to the funds withheld assets similar to invested assets held directly by the reinsurer. The assets in the funds withheld account including cash and cash equivalents, fixed income securities and derivatives are recorded in respective investment line items in the Consolidated Statements of Financial Position. These funds withheld assets are offset by recognizing corresponding funds withheld payable. The funds withheld payable includes an embedded derivative that is bifurcated from the host contract. The fair value of the embedded derivative is calculated based upon the change in the fair value of the underlying liabilities in the funds withheld agreement compared to the change in the fair value of the assets.
Participating insurance policies – for the majority of participating business, profits earned are reserved for the payment of dividends to policyholders, except for the stockholders’ share of profits on participating policies, which is limited to the greater of 10% of the profit on participating business, or 50 cents per thousand dollars of the face amount of participating life insurance in-force. Participating policyholders’ interest includes the accumulated net income from participating policies reserved for payment to such policyholders in the form of dividends (less net income allocated to stockholders as indicated above) as well as a pro rata portion of unrealized investment gains (losses).
For all other participating business, the allocation of dividends to participating policy owners is based upon a comparison of experienced rates of mortality, interest and expenses, as determined periodically for representative plans of insurance, issue ages and policy durations, with the corresponding rates assumed in the calculation of premiums.
It is included within “Other policyholder funds” in the Consolidated Statements of Financial Position.
Premium, Benefits, Claims incurred, and Expenses
Traditional ordinary life and health premiums are recognized as revenue when due. Benefits and expenses are associated with earned premiums to result in recognition of profits over the term of the insurance contracts.
Annuity premiums received on limited-pay and supplemental annuity contracts involving a significant life contingency are recognized as revenue when due. Revenues from deferred annuity contracts are principally surrender charges and living income benefit rider charges assessed against policyholder account balances during the period. In the case of variable annuities, revenues include administrative fees assessed to contract holders. Interest sensitive contract benefits related to annuity products include interest credited or index credits to policyholder account balances pursuant to accounting by insurance companies for certain long-duration contracts. The change in fair value of the embedded derivatives for fixed index annuities equals the change in the difference between policy benefit reserves for fixed index annuities computed under the derivative accounting standard and the long-duration contracts accounting standard at each balance sheet date. Insurance-related revenues including the change in the fair value of derivatives for call options related to the business ceded under coinsurance agreements, benefits, losses and expenses are reported net of reinsurance ceded.
Universal life and single premium whole life revenues represent amounts assessed to policyholders including mortality charges, surrender charges actually paid, and earned policy service fees. Amounts included in benefits are claims in excess of account balances returned to policyholders and interest credited to account balances.
Property and casualty premiums are recognized as revenue over the period of the contract in proportion to the amount of insurance protection, which is generally evenly over the contract period. Claims incurred consist of claims and CAE paid and the change in reserves.
Gross premiums for PRT issued are recognized as revenue when due and collection is reasonably assured. When premiums are recognized, future policy benefits are computed, the result being that benefits and expenses are matched with such revenue. Premiums ceded are recognized when due and in accordance with the terms of the contractual agreement between the Company and reinsurer. Premium refunds, if any, are recognized on an accrual basis. Policyholder benefits are recorded in the Consolidated Statements of Operations when they are due and incurred.
Pension and post-retirement benefit obligations and costsfor our frozen benefit plans are estimated using assumptions including demographic factors such as retirement age and mortality.
The Company uses a discount rate to determine the present value of future benefits on the measurement date. The guideline for setting this rate is a high-quality long-term corporate bond rate. For this purpose, a hypothetical bond portfolio to match the expected monthly benefit payments under the pension plan was constructed with the resulting yield of the portfolio used as a discount rate.
In developing the investment return assumption, we relied on a model that utilizes the following factors:
Current yield to maturity of fixed income securities
Forecasts of inflation, GDP growth and total return for each asset class
Historical plan performance
Target asset allocation
Standard deviations and correlations related to historical and expected future returns of each asset class and inflation
The resulting assumption is the assumed rate of return for the plans’ target asset allocation, net of investment expenses, and reflects anticipated returns of the plans’ current and future assets.
Using this approach, the calculated return will fluctuate from year to year; however, it is the Company’s policy to hold this long-term assumption relatively constant.
Interest income on investments measured at amortized cost is calculated using the effective interest method.
Dividend income is recognized when the right to receive payments is established.
Investment related gains (losses)include realized gains and losses on investments representing the difference between net sale proceeds and the carrying value, marked to market gains (losses) on investments carried at fair value, allowance for credit loss and foreign exchange gains (losses).
Current tax assets and liabilities are measured at the amount expected to be recovered from or paid to taxation authorities within a year. The tax rates and tax laws used to compute the amounts are those that are enacted or substantively enacted at the end of each year.
Deferred income tax – The Company accounts for deferred income taxes under the asset and liability method, which requires the recognition of deferred tax assets (“DTAs”) and deferred tax liabilities (“DTLs”) for the expected future tax consequences of events that have been included in the financial statements. Under this method, the Company determines DTAs and DTLs on the basis of the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on DTAs and DTLs is recognized in income in the period that includes the enactment date.
The Company recognizes DTAs to the extent that the assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, carryback potential if permitted under the tax law and results of recent operations. If the Company determines the DTAs will be realized in the future in excess of their net recorded amount, the Company would make an adjustment to the DTA valuation allowance, which would reduce the provision for income taxes. As of each reporting date, management considers new evidence, both positive and negative, that could affect its view of the future realization of deferred tax assets.
The Company records uncertain tax positions in accordance with Accounting Standards Codification (“ASC”) 740 on the basis of a two-step process in which (i) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (ii) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.
Segments – In accordance with ASC 280, Operating Segments, the Company uses a management approach to determine operating segments. The management approach considers the internal organization and reporting used by the Company’s chief operating decision maker (“CODM”) for making decisions, allocation of resources and assessing performance. The Company’s CODM has been identified as the Chief Executive Officer and the Chief Financial Officer who review the results of operations when making decisions about allocating resources and assessing the performance of the Company. Our operations are organized into four reportable segments: Life, Annuity, Property and Casualty and Corporate and Other (see Note 27 - Segment Reporting).
Litigation contingencies – Existing and potential litigation is reviewed quarterly to determine if any adjustments to liabilities for probable losses are necessary. Reserves for losses are established whenever they are probable and reasonably estimable. If not one estimate within the range of possible losses is more probable than any other, a reserve is recorded based on the lowest amount of the range.
Recently Issued Accounting Pronouncements
The Company continues to assess the impacts of the ASUs listed below that have been issued but not yet adopted as of June 30, 2024 on the financial statements. ASUs not listed below were assessed and determined to be either not applicable or insignificant in presentation or amount.
ASU 2023-02 – On March 29, 2023, the FASB issued ASU 2023-02, Investments—Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Tax Credit Structures Using the Proportional Amortization Method. The amendments permit reporting entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. In addition, disclosures describing the nature of the investments and related income tax credits and benefits will be required. This ASU was effective on January 1, 2024, to be applied on either a modified retrospective or a retrospective basis subject to certain exceptions, with early adoption permitted. The adoption of this standard did not have a material impact to the Company’s Consolidated Financial Statements or the Notes to the Consolidated Financial Statements.
ASU 2023-07 – On November 27, 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments require the disclosure of significant segment expenses by reportable segment, enhance interim disclosure requirements and clarify circumstances in which an entity can disclose multiple segment measures of profit or loss. This ASU is effective for fiscal periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, to be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact of this ASU on its Consolidated Financial Statements and the Notes to the Consolidated Financial Statements.
ASU 2023-09 – On December 14, 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments in this update require that public business entities on an annual basis (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5 percent of the amount computed by multiplying pretax income [or loss] by the applicable statutory income tax rate). This ASU will be effective on January 1, 2025, to be applied prospectively. The Company is currently evaluating the impact of this ASU on its Consolidated Financial Statements and the Notes to the Consolidated Financial Statements.
- Investments in Available-For-Sale Fixed Maturity Securities
The amortized cost and fair value of fixed maturity securities are shown below:
| Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Allowance for Credit Losses | Fair Value | |
|---|---|---|---|---|---|
| (Dollars in millions) | |||||
| Fixed maturity, available-for-sale: | |||||
| U.S. treasury and government | $85 | $— | $(2) | $— | $83 |
| U.S. states and political subdivisions | 3,240 | 84 | (25) | — | 3,299 |
| Foreign governments | 441 | 12 | — | — | 453 |
| Corporate debt securities | 32,080 | 481 | (578) | (34) | 31,949 |
| Residential mortgage-backed securities | 1,067 | 21 | (8) | (1) | 1,079 |
| Commercial mortgage-backed securities | 2,744 | 39 | (17) | — | 2,766 |
| Collateralized debt securities | 6,823 | 51 | (21) | (2) | 6,851 |
| Total investments in fixed maturity securities | $46,480 | $688 | $(651) | $(37) | $46,480 |
| Fixed maturity, available-for-sale: | |||||
| U.S. treasury and government | $63 | $— | $(1) | $— | $62 |
| U.S. states and political subdivisions | 594 | 1 | (17) | — | 578 |
| Foreign governments | 9 | — | — | — | 9 |
| Corporate debt securities | 11,144 | 79 | (420) | (19) | 10,784 |
| Residential mortgage-backed securities | 131 | — | (4) | (1) | 126 |
| Commercial mortgage-backed securities | — | — | — | — | — |
| Collateralized debt securities | 1,340 | 9 | (27) | (4) | 1,318 |
| Total investments in fixed maturity securities | $13,281 | $89 | $(469) | $(24) | $12,877 |
The amortized cost and fair value of fixed maturity securities at June 30, 2024, by contractual maturity are shown below. Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. All of our mortgage and collateralized debt securities provide for periodic payments throughout their lives and are shown below as separate lines.
| Amortized Cost | Fair Value | |
|---|---|---|
| (Dollars in millions) | ||
| Due in one year or less | $1,219 | $1,218 |
| Due after one year through five years | 12,048 | 11,982 |
| Due after five years through ten years | 7,416 | 7,363 |
| Due after ten years | 15,163 | 15,221 |
| 35,846 | 35,784 | |
| Residential mortgage-backed securities | 1,067 | 1,079 |
| Commercial mortgage-backed securities | 2,744 | 2,766 |
| Collateralized debt securities | 6,823 | 6,851 |
| $46,480 | $46,480 | |
Proceeds from sales of available-for-sale fixed maturity securities, with the related gross realized gains and losses, are shown below:
| Three Months EndedJune 30, | Six Months EndedJune 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (Dollars in millions) | ||||
| Proceeds from sales and maturities of investments - Fixed maturity, available for sale | $1,820 | $7,157 | $2,413 | $8,386 |
| Gross realized gains | 2 | 1 | 4 | 1 |
| Gross realized losses | (21) | (24) | (23) | (49) |
The Company has pledged bonds in connection with certain agreements and transactions, such as financing and reinsurance agreements. The carrying value of bonds pledged was $10.1 billion and $39 million as of June 30, 2024 and December 31, 2023, respectively.
In accordance with various regulations, the Company has securities on deposit with regulating authorities with a carrying value of $80 million and $54 million as of June 30, 2024 and December 31, 2023, respectively.
The gross unrealized losses and fair value of available-for-sale fixed maturity securities, aggregated by investment category and the length of time individual securities have been in a continuous unrealized loss position due to market factors are shown below:
| Less than 12 months | 12 months or more | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Number of Issues | Gross Unrealized Losses (1) | Fair Value | Number of Issues | Gross Unrealized Losses (1) | Fair Value | Number of Issues | Gross Unrealized Losses (1) | Fair Value | |
| (Dollars in millions) | |||||||||
| Fixed maturity, available-for-sale: | |||||||||
| U.S. treasury and government | 18 | $— | $23 | 15 | $(2) | $48 | 33 | $(2) | $71 |
| U.S. states and political subdivisions | 178 | (11) | 283 | 162 | (14) | 305 | 340 | (25) | 588 |
| Foreign governments | 3 | — | 16 | 1 | — | 9 | 4 | — | 25 |
| Corporate debt securities | 992 | (114) | 3,772 | 1,027 | (464) | 6,450 | 2,019 | (578) | 10,222 |
| Residential mortgage-backed securities | 59 | (4) | 82 | 35 | (4) | 75 | 94 | (8) | 157 |
| Commercial mortgage-backed securities | 124 | (17) | 846 | — | — | — | 124 | (17) | 846 |
| Collateralized debt securities | 349 | (14) | 2,707 | 39 | (7) | 292 | 388 | (21) | 2,999 |
| Total | 1,723 | $(160) | $7,729 | 1,279 | $(491) | $7,179 | 3,002 | $(651) | $14,908 |
| Fixed maturity, available-for-sale: | |||||||||
| U.S. treasury and government | 17 | $(1) | $27 | 35 | $— | $25 | 52 | $(1) | $52 |
| U.S. states and political subdivisions | 214 | (3) | 219 | 142 | (14) | 285 | 356 | (17) | 504 |
| Foreign governments | — | — | — | 2 | — | 9 | 2 | — | 9 |
| Corporate debt securities | 1,343 | (141) | 2,941 | 1,906 | (279) | 6,475 | 3,249 | (420) | 9,416 |
| Residential mortgage-backed securities | 6 | (1) | 39 | 39 | (3) | 64 | 45 | (4) | 103 |
| Commercial mortgage-backed securities | — | — | — | — | — | — | — | — | — |
| Collateralized debt securities | 102 | (4) | 258 | 201 | (23) | 782 | 303 | (27) | 1,040 |
| Total | 1,682 | $(150) | $3,484 | 2,325 | $(319) | $7,640 | 4,007 | $(469) | $11,124 |
(1)Unrealized losses have been reduced to reflect the allowance for credit losses of $37 million and $24 million as of June 30, 2024 and December 31, 2023, respectively.
The unrealized losses at June 30, 2024 are principally related to the timing of the purchases of certain securities, which carry less yield than those available at June 30, 2024. Approximately 94% and 87% of the unrealized losses on fixed maturity securities shown in the above table for June 30, 2024 and December 31, 2023, respectively, are on securities that are rated investment grade, defined as being the highest two NAIC designations.
We expect to recover our amortized cost on all securities except for those securities on which we recognized an allowance for credit loss. In addition, because we did not have the intent to sell fixed maturity securities with unrealized losses and it was not more likely than not that we would be required to sell these securities prior to recovery of the amortized cost, which may be maturity, we did not write down these investments to fair value through the Consolidated Statements of Operations.
Allowance for Credit Losses
Several assumptions and underlying estimates are made in the evaluation of allowance for credit loss. Examples include financial condition, near term and long-term prospects of the issue or issuer, including relevant industry conditions and trends and implications of rating agency actions and offering prices. Based on this evaluation, unrealized losses on available-for-sale securities where an allowance for credit loss was not recorded were concentrated within the financials sector as of June 30, 2024 (2023 – transportation sector).
The rollforward of the allowance for credit losses for available-for-sale fixed maturity securities is shown below for the three and six months ended June 30, 2024 and 2023.
| Corporate Securities | Residential Mortgage Backed Securities | Commercial Mortgage Backed Securities | Collateralized Debt Securities | Total | |
|---|---|---|---|---|---|
| (Dollars in millions) | |||||
| Beginning balance | $(24) | $(1) | $— | $(3) | $(28) |
| Acquisition from business combination | — | — | — | — | — |
| Credit losses recognized on securities for which credit losses were not previously recorded | (13) | — | — | — | (13) |
| Reductions for securities sold during the period | — | — | — | — | — |
| Allowance on securities that had an allowance recorded in a previous period | 3 | — | — | 1 | 4 |
| Balance as of June 30, 2024 | $(34) | $(1) | $— | $(2) | $(37) |
| Corporate Securities | Residential Mortgage Backed Securities | Commercial Mortgage Backed Securities | Collateralized Debt Securities | Total | |
| (Dollars in millions) | |||||
| Beginning balance | $(12) | $— | $— | $(10) | $(22) |
| Acquisition from business combination | — | — | — | — | — |
| Credit losses recognized on securities for which credit losses were not previously recorded | (17) | (1) | — | (1) | (19) |
| Reductions for securities sold during the period | 1 | — | — | — | 1 |
| Allowance on securities that had an allowance recorded in a previous period | 6 | — | — | 2 | 8 |
| Balance as of June 30, 2023 | $(22) | $(1) | $— | $(9) | $(32) |
| Corporate Securities | Residential Mortgage Backed Securities | Commercial Mortgage Backed Securities | Collateralized Debt Securities | Total | |
| (Dollars in millions) | |||||
| Beginning balance | $(19) | $(1) | $— | $(4) | $(24) |
| Acquisition from business combination | — | — | — | — | — |
| Credit losses recognized on securities for which credit losses were not previously recorded | (33) | — | — | — | (33) |
| Reductions for securities sold during the period | 1 | — | — | — | 1 |
| Allowance on securities that had an allowance recorded in a previous period | 17 | — | — | 1 | 18 |
| Balance as of June 30, 2024 | $(34) | $(1) | $— | $(2) | $(37) |
| Corporate Securities | Residential Mortgage Backed Securities | Commercial Mortgage Backed Securities | Collateralized Debt Securities | Total | |
| (Dollars in millions) | |||||
| Beginning balance | $(24) | $— | $— | $(5) | $(29) |
| Acquisition from business combination | — | — | — | — | — |
| Credit losses recognized on securities for which credit losses were not previously recorded | (18) | (1) | — | (6) | (25) |
| Reductions for securities sold during the period | 2 | — | — | — | 2 |
| Allowance on securities that had an allowance recorded in a previous period | 18 | — | — | 2 | 20 |
| Balance as of June 30, 2023 | $(22) | $(1) | $— | $(9) | $(32) |
- Equity Securities
The net gains (losses) on equity securities recognized in “Investment related gains (losses)” on the Consolidated Statements of Operations are shown below:
| Three Months EndedJune 30, | Six Months EndedJune 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (Dollars in millions) | ||||
| Unrealized gains (losses) on equity securities | $33 | $71 | $22 | $42 |
| Net gains (losses) on equity securities sold | 2 | — | 2 | 1 |
| Net gains (losses) on equity securities | $35 | $71 | $24 | $43 |
Equity securities by market sector distribution are shown below, based on carrying value:
| June 30, 2024 | December 31, 2023 | |
|---|---|---|
| Energy and utilities | 33% | 30% |
| Finance | 22% | 24% |
| Healthcare | 7% | 9% |
| Industrials | 4% | 3% |
| Information technology | 25% | 18% |
| Other | 9% | 16% |
| Total | 100% | 100% |
- Mortgage Loans on Real Estate
Our mortgage loan investments consist of the followingtwo portfolio segments: commercial mortgage loans and residential mortgage loans. Our mortgage loan portfolios are summarized in the following table.
| June 30, 2024 | December 31, 2023 | |
|---|---|---|
| (Dollars in millions) | ||
| Commercial mortgage loans: | ||
| Principal outstanding | $9,778 | $5,870 |
| Deferred fees and costs, net | (73) | (72) |
| Unamortized discounts and premiums, net | (530) | (87) |
| Amortized cost | 9,175 | 5,711 |
| Allowance for credit losses | (54) | (53) |
| Commercial mortgage loans, carrying value | 9,121 | 5,658 |
| Residential mortgage loans: | ||
| Principal outstanding | 3,145 | 57 |
| Deferred fees and costs, net | (132) | (57) |
| Unamortized discounts and premiums, net | (92) | — |
| Amortized cost | 2,921 | — |
| Allowance for credit losses | — | — |
| Residential mortgage loans, carrying value | 2,921 | — |
| Mortgage loans, carrying value | $12,042 | $5,658 |
Our commercial mortgage loan portfolio consists of loans collateralized by the related properties and diversified as to property type, location and loan size. Our lending policies establish limits on the amount that can be loaned to one borrower and other criteria to attempt to reduce the risk of default. The commercial mortgage loan portfolio is summarized by geographic region and property type as follows:
| June 30, 2024 | December 31, 2023 | |||
|---|---|---|---|---|
| Amortized Cost | Percent | Amortized Cost | Percent | |
| (Dollars in millions) | ||||
| Geographic distribution | ||||
| Pacific | $1,804 | 19.7% | $905 | 15.9% |
| Mountain | 1,802 | 19.6% | 1,327 | 23.2% |
| West North Central | 280 | 3.1% | 178 | 3.1% |
| West South Central | 1,436 | 15.6% | 1,081 | 18.9% |
| East North Central | 1,040 | 11.3% | 829 | 14.5% |
| East South Central | 150 | 1.6% | 50 | 0.9% |
| Middle Atlantic | 374 | 4.1% | 129 | 2.3% |
| South Atlantic | 1,982 | 21.6% | 1,000 | 17.5% |
| New England | 106 | 1.2% | 12 | 0.2% |
| Other | 201 | 2.2% | 200 | 3.5% |
| 9,175 | 100.0% | 5,711 | 100.0% | |
| Allowance for credit losses | (54) | (53) | ||
| Total, net of allowance | $9,121 | $5,658 | ||
| Property type distribution | ||||
| Apartment | $2,063 | 22.5% | $1,091 | 19.1% |
| Hotel | 1,210 | 13.2% | 966 | 16.9% |
| Industrial | 1,926 | 21.0% | 1,052 | 18.4% |
| Office | 1,222 | 13.3% | 999 | 17.5% |
| Parking | 319 | 3.5% | 414 | 7.2% |
| Retail | 1,479 | 16.1% | 781 | 13.7% |
| Storage | 180 | 2.0% | 118 | 2.1% |
| Other | 776 | 8.4% | 290 | 5.1% |
| 9,175 | 100.0% | 5,711 | 100.0% | |
| Allowance for credit losses | (54) | (53) | ||
| Total, net of allowance | $9,121 | $5,658 | ||
Our residential mortgage loan portfolio consists of loans with an amortized cost of $2.9 billion and $0 million as of June 30, 2024 and December 31, 2023, respectively. These loans are collateralized by the related properties and diversified as to location within the United States.
Mortgage loans on real estate are generally reported at cost adjusted for amortization of premiums and accrual of discounts, computed using the interest method and net of valuation allowances. Interest income is accrued on the principal amount of the loan based on the loan's contractual interest rate. Interest income is included in Net investment income on our Consolidated Statements of Operations. Accrued interest receivable, which was $94 million and $27 million as of June 30, 2024 and December 31, 2023, respectively, is included in Accrued investment income on our Consolidated Statements of Financial Position.
Loan Valuation Allowance
We establish a valuation allowance to provide for the risk of credit losses inherent in our mortgage loan portfolios. The valuation allowance is maintained at a level believed adequate by management to absorb estimated expected credit losses. The valuation allowance is based on amortized cost, which excludes accrued interest receivable. We do not measure a credit loss allowance on accrued interest receivable as we write off any uncollectible accrued interest receivable balances to net investment income in a timely manner. We charged off $1 million and $1 million of uncollectible accrued interest receivable on our mortgage loan portfolios for the three and six months periods ended June 30, 2024, respectively. We didnot charge off any uncollectible accrued interest receivable on our mortgage loan portfolios for the three and six months periods ended June 30, 2023, respectively.
The valuation allowances for each of our mortgage loan portfolios are estimated by deriving probability of default and recovery rate assumptions based on the characteristics of the loans in each portfolio, historical economic data and loss information, and current and forecasted economic conditions. Key loan characteristics impacting the estimate for our commercial mortgage loan portfolio include the current state of the borrower’s credit quality, which considers factors such as loan-to-value (“LTV”) and debt service coverage (“DSC”) ratios, loan performance, underlying collateral type, delinquency status, time to maturity, and original credit scores. Key loan characteristics impacting the estimate for our residential mortgage loan portfolios include the current state of the borrowers' credit quality, delinquency status, time to maturity and original credit scores.
The following table represents a rollforward of the allowance for credit losses on our mortgage loan portfolios:
| Three Months Ended June 30, 2024 | |||
|---|---|---|---|
| Commercial | Residential | Total | |
| (Dollars in millions) | |||
| Beginning allowance balance | $(54) | $— | $(54) |
| Acquisition from business combination | — | — | — |
| Provision | — | — | — |
| Writeoffs charged against the allowance | — | — | — |
| Recoveries of amounts previously written off | — | — | — |
| Ending allowance balance | $(54) | $— | $(54) |
| Three Months Ended June 30, 2023 | |||
| Commercial | Residential | Total | |
| (Dollars in millions) | |||
| Beginning allowance balance | $(49) | $— | $(49) |
| Acquisition from business combination | — | — | — |
| Provision | 6 | — | 6 |
| Writeoffs charged against the allowance | — | — | — |
| Recoveries of amounts previously written off | — | — | — |
| Ending allowance balance | $(43) | $— | $(43) |
| Six Months Ended June 30, 2024 | |||
| Commercial | Residential | Total | |
| (Dollars in millions) | |||
| Beginning allowance balance | $(53) | $— | $(53) |
| Acquisition from business combination | — | — | — |
| Provision | (1) | — | (1) |
| Writeoffs charged against the allowance | — | — | — |
| Recoveries of amounts previously written off | — | — | — |
| Ending allowance balance | $(54) | $— | $(54) |
| Six Months Ended June 30, 2023 | |||
| Commercial | Residential | Total | |
| (Dollars in millions) | |||
| Beginning allowance balance | $(38) | $— | $(38) |
| Acquisition from business combination | — | — | — |
| Provision | (5) | — | (5) |
| Writeoffs charged against the allowance | — | — | — |
| Recoveries of amounts previously written off | — | — | — |
| Ending allowance balance | $(43) | $— | $(43) |
Charge-offs include allowances that have been established on loans that were satisfied either by taking ownership of the collateral or by some other means such as discounted pay-off or loan sale. When ownership of the property is taken it is recorded at the lower of the loan's carrying value or the property's fair value (based on appraised values) less estimated costs to sell. The real estate owned is recorded as a component of Real estate investments and the loan is recorded as fully paid, with any allowance for credit loss that has been established charged off. Fair value of the real estate is determined by third party appraisal. There were 13 real estate properties totaling $68 million at June 30, 2024 and 3 real estate properties totaling $79 million at December 31, 2023, in which ownership of the property was taken to satisfy an outstanding loan at December 31, 2023. Recoveries are situations where we have received a payment from the borrower in an amount greater than the carrying value of the loan (principal outstanding less specific allowance).
We closely monitor loan performance for our commercial and residential mortgage loan portfolios. Aging of financing receivables is summarized in the following table (by year of origination):
| Amortized Cost Basis by Origination Year | |||||||
|---|---|---|---|---|---|---|---|
| 2024 | 2023 | 2022 | 2021 | 2020 | Prior | Total | |
| As of June 30, 2024: · (Dollars in millions) | |||||||
| Commercial mortgage loans | |||||||
| Current | $214 | $415 | $2,215 | $1,254 | $983 | $3,867 | $8,948 |
| 30 - 59 days past due | — | — | — | — | — | 24 | 24 |
| 60 - 89 days past due | — | 2 | 50 | — | — | 42 | 94 |
| Non-accrual (90 days or more past due) | — | 3 | — | 1 | — | 105 | 109 |
| Total commercial mortgage loans | $214 | $420 | $2,265 | $1,255 | $983 | $4,038 | $9,175 |
| Residential mortgage loans | |||||||
| Current | $64 | $1,030 | $1,193 | $251 | $127 | $17 | $2,682 |
| 30 - 59 days past due | 3 | 16 | 41 | 10 | 5 | — | 75 |
| 60 - 89 days past due | — | 14 | 21 | 7 | 4 | 1 | 47 |
| Non-accrual (90 days or more past due) | — | 36 | 50 | 20 | 9 | 2 | 117 |
| Total residential mortgage loans | $67 | $1,096 | $1,305 | $288 | $145 | $20 | $2,921 |
| Total mortgage loans | $281 | $1,516 | $3,570 | $1,543 | $1,128 | $4,058 | $12,096 |
| Allowance for credit losses | (54) | ||||||
| Total, net of allowance | $12,042 | ||||||
| Amortized Cost Basis by Origination Year | |||||||
| 2023 | 2022 | 2021 | 2020 | 2019 | Prior | Total | |
| As of December 31, 2023: | (Dollars in millions) | ||||||
| Commercial mortgage loans | |||||||
| Current | $319 | $1,486 | $679 | $489 | $488 | $2,120 | $5,581 |
| 30 - 59 days past due | — | 26 | — | — | 5 | 21 | 52 |
| 60 - 89 days past due | — | 50 | — | — | — | 13 | 63 |
| Non-accrual (90 days or more past due) | — | — | — | — | — | 15 | 15 |
| Total commercial mortgage loans | $319 | $1,562 | $679 | $489 | $493 | $2,169 | $5,711 |
| Residential mortgage loans | |||||||
| Current | $— | $— | $— | $— | $— | $— | $— |
| 30 - 59 days past due | — | — | — | — | — | — | — |
| 60 - 89 days past due | — | — | — | — | — | — | — |
| Non-accrual (90 days or more past due) | — | — | — | — | — | — | — |
| Total residential mortgage loans | $— | $— | $— | $— | $— | $— | $— |
| Total mortgage loans | $319 | $1,562 | $679 | $489 | $493 | $2,169 | $5,711 |
| Allowance for credit losses | (53) | ||||||
| Total, net of allowance | $5,658 | ||||||
Commercial and residential mortgage loans are considered nonperforming when they become 90 days or more past due. When loans become nonperforming, we place them on non-accrual status and discontinue recognizing interest income. If payments are received on a nonperforming loan, interest income is recognized to the extent it would have been recognized if normal principal and interest would have been received timely. If payments are received to bring a nonperforming loan back to less than 90 days past due, we will resume accruing interest income on that loan. There were 206 loans in non-accrual status at June 30, 2024 and 3 loans in non-accrual status at December 31, 2023. During the three and six months ended June 30, 2024 we recognized interest income of $1 million and $1 million on loans which were in non-accrual status at the respective period end. During the three and six months ended June 30, 2023 we recognizedno interest income on loans which were in non-accrual status at the respective period end.
Loan Modifications
Our commercial and residential mortgage loans may be subject to loan modifications. Loan modifications may be granted to borrowers experiencing financial difficulty and could include principal forgiveness, interest rate reduction, an other-than-significant delay or a term extension. We consider the following factors in determining whether or not a borrower is experiencing financial difficulty:
borrower is in default,
borrower has declared bankruptcy,
there is growing concern about the borrower's ability to continue as a going concern,
borrower has insufficient cash flows to service debt,
borrower's inability to obtain funds from other sources, and
there is a breach of financial covenants by the borrower.
A loan modification typically does not result in a change in valuation allowance as it is already incorporated into our allowance methodology. However, if we grant a borrower experiencing financial difficulty principal forgiveness, the amount of principal forgiven would be written off, which would reduce the amortized cost of the loan and result in an adjustment to the valuation allowance.
There were three andseven significant mortgage loan modifications for the three and six months ended June 30, 2024, respectively, andthree andfive significant mortgage loan modifications for the three and six months ended June 30, 2023, respectively.
- Private Loans
The following table summarizes the credit ratings for private loans:
| June 30, 2024 | December 31, 2023 | |
|---|---|---|
| (Dollars in millions) | ||
| AAA | $— | $— |
| AA | 72 | — |
| A | 926 | — |
| BBB | 35 | — |
| BB and below | 604 | 194 |
| Unrated (1) | 87 | — |
| Total | $1,724 | $194 |
(1)Due to the nature of private loans, external agency credit ratings may not be readily available. Where appropriate, the Company obtains non-published credit ratings from one or more third-party rating agencies, which are determined based on an independent evaluation of the transaction. For other loans without published or private credit ratings, the Company assigns internal risk ratings, based on our investment selection and monitoring process and policies. These internal risk ratings are categorized as “Unrated” above.
Allowance for Credit Losses
The rollforward of the allowance for credit losses for private loans is shown below:
| 2024 | 2023 | |
|---|---|---|
| (Dollars in millions) | ||
| Balance at January 1 | $(8) | $— |
| Acquisition from business combination | — | — |
| Provision | 1 | — |
| Writeoffs charged against the allowance | — | — |
| Recoveries of amounts previously written off | — | — |
| Balance at March 31 | (7) | — |
| Acquisition from business combination | — | — |
| Provision | (14) | — |
| Writeoffs charged against the allowance | — | — |
| Recoveries of amounts previously written off | — | — |
| Balance at June 30 | $(21) | $— |
- Real Estate and Real Estate Partnerships
The carrying amounts of real estate investments are as follows:
| Real Estate | ||
|---|---|---|
| Amount | Percentage | |
| (Dollars in millions) | ||
| Hotel | $137 | 7% |
| Industrial | 28 | 1% |
| Land | 129 | 6% |
| Office | 236 | 12% |
| Retail | 230 | 11% |
| Apartments | — | —% |
| Single family residential | 1,279 | 62% |
| Other | 11 | 1% |
| Total real estate | 2,050 | 100% |
| Real estate partnerships | 4,279 | |
| Total real estate and real estate partnerships | $6,329 | |
| Real Estate | ||
| Amount | Percentage | |
| (Dollars in millions) | ||
| Hotel | $14 | 2% |
| Industrial | 65 | 9% |
| Land | 37 | 5% |
| Office | 358 | 47% |
| Retail | 218 | 29% |
| Apartments | 60 | 8% |
| Single family residential | — | —% |
| Other | 3 | —% |
| Total real estate | 755 | 100% |
| Real estate partnerships | 2,856 | |
| Total real estate and real estate partnerships | $3,611 | |
As of June 30, 2024 and December 31, 2023, no real estate investments met the criteria as held-for-sale.
- Variable Interest Entities and Equity Method Investments
The Company regularly invests in real estate partnerships and investment funds and frequently participates in the design with the sponsor, but in most cases, its involvement is limited to financing. Some of these investments have been determined to be variable interest entities (“VIEs”). In certain instances, in addition to an economic interest in the entity, the Company holds the power to direct the most significant activities of the entity and is deemed the primary beneficiary. The Company consolidates all VIEs in which it is the primary beneficiary. The assets of consolidated VIEs are restricted and must first be used to settle their liabilities. Creditors or beneficial interest holders of these VIEs have no recourse to the general credit of the Company, as the Company’s obligation is limited to the amount of its committed investment. The Company has not provided financial or other support to these consolidated VIEs in the form of liquidity arrangements, guarantees or other commitments to third-parties that may affect the fair value or risk of its variable interest in these VIEs as of June 30, 2024 and December 31, 2023.
Consolidated Variable Interest Entities
The assets and liabilities relating to the consolidated VIEs included in the financial statements are as follows:
| June 30, 2024 | December 31, 2023 | |
|---|---|---|
| (Dollars in millions) | ||
| Fixed maturity securities, available for sale | $44 | $63 |
| Equity securities, at fair value | 115 | 15 |
| Private loans | 196 | 188 |
| Real estate | 1,628 | 172 |
| Real estate partnerships | 1,055 | — |
| Investment funds | 487 | 4 |
| Short-term investments | — | 4 |
| Other invested assets | 150 | — |
| Cash and cash equivalents | 132 | 26 |
| Other assets | 158 | 61 |
| Total assets of consolidated VIEs | $3,965 | $533 |
| Notes payable | $175 | $174 |
| Other liabilities | 94 | 14 |
| Total liabilities of consolidated VIEs | $269 | $188 |
Unconsolidated Variable Interest Entities
For unconsolidated VIEs, the Company is not the primary beneficiary as major decisions impacting the economic activities of the VIE require consent from one or more other partners. These unconsolidated VIEs are accounted for using the equity method of accounting or at amortized cost. In addition, certain equity securities and available-for-sale fixed maturity securities at fair value are the Company’s interests in limited partnerships that are unconsolidated VIEs. Creditors or beneficial interest holders of these VIEs have no recourse to the general credit of the Company, as the Company’s obligation is limited to the amount of its committed investment. The Company has not provided financial or other support to these unconsolidated VIEs in the form of liquidity arrangements, guarantees or other commitments to third-parties that may affect the fair value or risk of its variable interest in these VIEs as of June 30, 2024 and December 31, 2023.
The carrying amount and maximum exposure to loss relating to these unconsolidated VIEs are as follows:
| June 30, 2024 | December 31, 2023 | |||
|---|---|---|---|---|
| CarryingAmount | MaximumExposure to Loss | CarryingAmount | MaximumExposure to Loss | |
| (Dollars in millions) | ||||
| Fixed maturity securities, available for sale | $2,100 | $2,100 | $— | $— |
| Mortgage loans on real estate | 673 | 746 | 632 | 632 |
| Real estate partnerships | 889 | 892 | 301 | 301 |
| Short-term investments | 57 | 57 | — | — |
| Other invested assets | 157 | 157 | — | — |
| Total | $3,876 | $3,952 | $933 | $933 |
Equity Method Investments
The Company’s investments in investment funds, real estate partnerships, and other partnerships of which substantially all are limited liability companies (“LLCs”) or limited partnerships are accounted for using the equity method of accounting. As of June 30, 2024 and December 31, 2023, the Company’s equity accounted investments totaled $4.3 billion and $4.4 billion, respectively.
As described in Note 2 - Summary of Significant Accounting Policies, the Company generally recognizes its share of earnings in its equity method investments within “Net investment income” using a three-month lag in instances where the investee’s financial information is not sufficiently timely or when the investee’s reporting period differs from the Company’s reporting period.
The following aggregated summarized financial data reflects the latest available financial information and does not represent the Company’s pro rata share of the assets, liabilities or earnings of such entities. Aggregated total assets of these entities totaled $37.8 billion and $4.4 billion as of June 30, 2024 and December 31, 2023, respectively. Aggregate net income of these entities totaled $65 million and $103 million for the three and six months ended June 30, 2024 and $30 million and $66 million for the three and six months ended June 30, 2023, respectively. Aggregate net income from the underlying entities in which the Company invests primarily comprise investment income, including recurring investment income (loss) and realized and unrealized investment gains (losses), from investment funds, real estate properties and real estate funds.
- Derivative Instruments
The Company manages risks associated with certain assets and liabilities by using derivative financial instruments. Derivative financial instruments are financial contracts whose value is derived from underlying interest rates, exchange rates or other financial instruments. The Company does not invest in derivatives for speculative purposes.
Equity-indexed options are over-the-counter contractual agreements negotiated between counterparties. The Company purchases equity-indexed options as economic hedges against fluctuations in the equity markets to which equity-indexed products are exposed. Equity-indexed contracts include a fixed host universal-life insurance or annuity contract and an equity-indexed embedded derivative.
The notional principal represents the amount to which a rate or price is applied to determine the cash flows to be exchanged periodically and does not represent credit exposure. Maximum credit risk is the estimated cost of replacing derivative financial instruments which have a positive value, should the counterparty default.
Derivatives, except for embedded derivatives, are included in “Other invested assets”, at fair value in the Consolidated Statements of Financial Position. Embedded derivative liabilities on funds withheld and modified coinsurance (“Modco”) arrangements and embedded derivative liabilities on indexed annuity and variable annuity products are included in the Consolidated Statements of Financial Position within the “Reinsurance funds withheld” and “Policyholders’ account balances” lines respectively, at fair value.
The notional and fair values of derivative instruments, presented in the Consolidated Statements of Financial Position, are shown below:
| PrimaryUnderlyingRisk · Location in the ConsolidatedStatements of Financial Position · June 30, 2024 · December 31, 2023 | ||||||||
|---|---|---|---|---|---|---|---|---|
| NotionalAmount · Carrying Value / Fair Value · NotionalAmount · Carrying Value / Fair Value | ||||||||
| Assets · Liabilities · Assets · Liabilities | ||||||||
| (Dollars in millions) | ||||||||
| Derivatives Not Designated as Hedging Instruments: | ||||||||
| Equity-indexed options | Equity | Other invested assets, Other liabilities | $45,871 | $1,610 | $— | $4,084 | $227 | $— |
| Embedded Derivatives: | ||||||||
| Indexed annuity and variable annuity product | Interest rate | Policyholders’ account balances | — | — | 1,196 | — | — | 873 |
| Funds withheld and Modco arrangements | Interest rate | Funds withheld for reinsurance liabilities | — | — | 79 | — | — | — |
| $45,871 | $1,610 | $1,275 | $4,084 | $227 | $873 | |||
Derivatives Not Designated as Hedging Instruments
The following represents the financial statement location and amount of gains (losses) related to the derivatives not designated as hedging instruments:
| Derivative Gains (Losses) Recognized in Income | |||||
|---|---|---|---|---|---|
| Three Months EndedJune 30, · Six Months EndedJune 30, | |||||
| Location in the Consolidated Statements of Operations | 2024 | 2023 | 2024 | 2023 | |
| (Dollars in millions) | |||||
| Equity-indexed options | Change in fair value of insurance-related derivatives and embedded derivatives | $308 | $46 | $365 | $71 |
| Embedded derivatives: | |||||
| Indexed annuity and variable annuity product | Change in fair value of insurance-related derivatives and embedded derivatives | (250) | (20) | (288) | (71) |
| Funds withheld and Modco arrangements | Change in fair value of insurance-related derivatives and embedded derivatives | (79) | — | (79) | — |
| $(21) | $26 | $(2) | $— | ||
Derivative Exposure
The Company’s use of derivative instruments exposes it to credit risk in the event of non-performance by counterparties. The Company has a policy of only dealing with counterparties it believes are creditworthy and obtaining sufficient collateral where appropriate, as a means to mitigating the financial loss from defaults. The Company holds collateral in cash and notes secured by U.S. government-backed assets. The non-performance risk is the net counterparty exposure based on fair value of open contracts less fair value of collateral held. The Company maintains master netting agreements with its current active trading partners. A right of offset has been applied to collateral that supports credit risk and has been recorded in the Consolidated Statements of Financial Position as an offset to “Other invested assets” with an associated payable to “Other liabilities” for excess collateral. A right of offset has also been applied to derivative assets and liabilities with the same counterparty under the same master netting agreement, and such derivative instruments are presented on a net basis in the Consolidated Statements of Financial Position.
The fair value of our call options by counterparty and each counterparty's current credit rating are as follows:
| June 30, 2024 · December 31, 2023 | ||||
|---|---|---|---|---|
| Counterparty | Credit Rating (S&P) | Credit Rating (Moody's) | Fair Value | Fair Value |
| (Dollars in millions) | ||||
| Bank of America | A+ | Aa1 | $162 | $24 |
| Barclays | A+ | A1 | 76 | 24 |
| Canadian Imperial Bank of Commerce | A+ | Aa2 | 61 | — |
| Citibank, N.A. | A+ | Aa3 | 46 | — |
| Credit Suisse | A+ | Aa2 | 6 | 16 |
| Goldman Sachs | A+ | A1 | 17 | — |
| ING | A- | Baa1 | 6 | 10 |
| J.P. Morgan | A+ | Aa2 | 149 | 12 |
| Mizuho | A | A1 | 393 | — |
| Morgan Stanley | A+ | Aa3 | 114 | 43 |
| NATIXIS | A+ | A2 | 2 | 4 |
| Royal Bank of Canada | AA- | A1 | 132 | — |
| Societe Generale | A | A1 | 82 | — |
| Truist | A | A3 | 119 | 59 |
| UBS AG | A+ | Aa3 | 50 | — |
| Wells Fargo | A+ | Aa2 | 195 | 35 |
| $1,610 | $227 | |||
Information regarding the Company’s exposure to credit loss on the derivatives it holds, including the effect of rights of offset, is presented below:
| Gross Amountof DerivativeInstruments(1) | Gross AmountOffset in theConsolidatedStatements ofFinancial Position | Net AmountPresented in theConsolidated Statements ofFinancial Position | Collateral(Received)Pledgedin Cash(2) | Collateral(Received)Pledged inInvested Assets(2) | Exposureof NetCollateral | |
|---|---|---|---|---|---|---|
| (Dollars in millions) | ||||||
| Derivative assets | ||||||
| Equity-indexed options | $1,618 | $(8) | $1,610 | $(1,587) | $(21) | $2 |
| Total derivative assets | $1,618 | $(8) | $1,610 | $(1,587) | $(21) | $2 |
| Derivative liabilities | ||||||
| Equity-indexed options | $(8) | $8 | $— | $— | $— | $— |
| Total derivative liabilities | $(8) | $8 | $— | $— | $— | $— |
| Derivative assets | ||||||
| Equity-indexed options | $227 | $— | $227 | $(205) | $(21) | $1 |
| Total derivative assets | $227 | $— | $227 | $(205) | $(21) | $1 |
| Derivative liabilities | ||||||
| Equity-indexed options | $— | $— | $— | $— | $— | $— |
| Total derivative liabilities | $— | $— | $— | $— | $— | $— |
(1)Represents derivative assets and liabilities on a gross basis, which are not offset under enforceable master netting agreements that meet all offsetting criteria.
(2)Excludes a portion of collateral held in cash and invested assets that are excess collateral. As of June 30, 2024 and December 31, 2023, the Company held excess collateral of $52 million and $4 million, respectively.
- Net Investment Income and Investment Related Gains (Losses)
Net investment income is shown below:
| Three Months EndedJune 30, | Six Months EndedJune 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (Dollars in millions) | ||||
| Available-for-sale fixed maturity securities | $433 | $167 | $661 | $324 |
| Equity securities | 6 | — | 21 | — |
| Mortgage loans | 160 | 73 | 238 | 142 |
| Private loans | 1 | — | 1 | — |
| Real estate | 39 | 1 | 52 | 5 |
| Real estate partnerships | 6 | (1) | 6 | 15 |
| Investment funds | 133 | 31 | 168 | 50 |
| Policy loans | 6 | — | 6 | — |
| Short-term investments | 45 | 58 | 77 | 92 |
| Other | 95 | 13 | 142 | 38 |
| Total net investment income | $924 | $342 | $1,372 | $666 |
Net unrealized and realized investment gains (losses) are shown below:
| Three Months EndedJune 30, | Six Months EndedJune 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (Dollars in millions) | ||||
| Available-for-sale fixed maturity securities | $(33) | $(35) | $(25) | $(60) |
| Equity securities | 35 | 71 | 24 | 43 |
| Mortgage loans | 2 | 2 | (6) | (10) |
| Private loans | (3) | — | (3) | — |
| Short-term investments and other invested assets | 1 | 3 | (22) | 7 |
| Total investment related gains (losses), net | $2 | $41 | $(32) | $(20) |
- Fair Value of Financial Instruments
The carrying amount and fair value of financial instruments are shown below:
| June 30, 2024 | December 31, 2023 | |||
|---|---|---|---|---|
| Carrying Amount | Fair Value | Carrying Amount | Fair Value | |
| (Dollars in millions) | ||||
| Financial assets: | ||||
| Available-for-sale fixed maturity securities | $46,480 | $46,480 | $12,877 | $12,877 |
| Equity securities | 1,200 | 1,200 | 1,404 | 1,404 |
| Mortgage loans on real estate, net of allowance | 12,042 | 11,812 | 5,658 | 5,405 |
| Private loans, net of allowance | 1,724 | 1,729 | 194 | 194 |
| Policy loans | 401 | 401 | 390 | 390 |
| Short-term investments | 1,945 | 1,945 | 2,397 | 2,397 |
| Other invested assets: | ||||
| Derivative assets | 1,610 | 1,610 | 227 | 227 |
| Collaterals received on derivatives (excluding excess collateral) | (1,587) | (1,587) | (226) | (226) |
| Separately managed accounts | 89 | 89 | 105 | 105 |
| Other (1) | 832 | 832 | 14 | 14 |
| Cash and cash equivalents | 13,895 | 13,895 | 3,192 | 3,192 |
| Reinsurance recoverables and deposit assets | 15,261 | 14,196 | — | — |
| Other assets - market risk benefits | 704 | 704 | 34 | 34 |
| Separate account assets (2) | 1,266 | 1,266 | 1,189 | 1,189 |
| Total financial assets | $95,862 | $94,572 | $27,455 | $27,202 |
| Financial liabilities: | ||||
| Policyholders' account balances, excluding embedded derivative | $76,797 | $76,797 | $14,097 | $14,097 |
| Policyholders’ account balances – embedded derivative | 1,196 | 1,196 | 873 | 873 |
| Market risk benefits | 3,276 | 3,276 | 34 | 34 |
| Other liabilities: | ||||
| Funds withheld liabilities | 79 | 79 | — | — |
| Notes payable | 657 | 657 | 174 | 174 |
| Long term borrowings | 2,476 | 2,458 | 1,493 | 1,493 |
| Separate account liabilities (2) | 1,266 | 1,266 | 1,189 | 1,189 |
| Total financial liabilities | $85,747 | $85,729 | $17,860 | $17,860 |
(1)Balance includes $407 million and $14 million other invested assets not subject to fair value hierarchy as of June 30, 2024 and December 31, 2023, respectively.
(2)Balance includes $32 million and $26 million of assets, and corresponding liabilities, that are not subject to fair value hierarchy as of June 30, 2024 and December 31, 2023, respectively.
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability. A fair value hierarchy is used to determine fair value based on a hypothetical transaction as of the measurement date from the perspective of a market participant. The Company has evaluated the types of securities in its investment portfolio to determine an appropriate hierarchy level based upon trading activity and the observability of market inputs. The classification of assets or liabilities within the fair value hierarchy is based on the lowest level of significant input to its valuation. The input levels are defined as follows:
Level 1 -Unadjusted quoted prices in active markets for identical assets or liabilities
Level 2 -Quoted prices in markets that are not active or inputs that are observable directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities other than quoted prices in Level 1; quoted prices in markets that are not active; or other inputs that are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities
Level 3 -Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. Unobservable inputs reflect the Company’s own assumptions about the assumptions that market participants would use in pricing the asset or liability. Level 3 assets and liabilities include financial instruments whose values are determined using pricing models and third-party evaluation, as well as instruments for which the determination of fair value requires significant management judgment or estimation
Valuation Techniques for Financial Instruments Recorded at Fair Value
Available-for-sale Fixed Maturity Securities and Equity Options — The Company utilizes pricing services to estimate fair value measurements. The fair value for available-for-sale fixed maturity securities that are disclosed as Level 1 measurements are based on unadjusted quoted market prices for identical assets that are readily available in an active market. The estimates of fair value for most available-for-sale fixed maturity securities, including municipal bonds, provided by the pricing service are disclosed as Level 2 measurements as the estimates are based on observable market information rather than market quotes. The pricing service utilizes market quotations for available-for-sale fixed maturity securities that have quoted prices in active markets. Since available-for-sale fixed maturity securities generally do not trade on a daily basis, the pricing service prepares estimates of fair value measurements for these securities using its proprietary pricing applications, which include available relevant market information, benchmark curves, benchmarking of like securities, sector groupings and matrix pricing. Additionally, an option adjusted spread model is used to develop prepayment and interest rate scenarios.
The pricing service evaluates each asset class based on relevant market information, credit information, perceived market movements and sector news. The market inputs utilized in the pricing evaluation, listed in the approximate order of priority, include: benchmark yields, reported trades, pricing source quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, reference data, and economic events. The extent of the use of each market input depends on asset class and the market conditions. Depending on the security, the priority of the use of inputs may change or some market inputs may not be relevant. For some securities, additional inputs may be necessary.
The Company has reviewed the inputs and methodology used and the techniques applied by the pricing service to produce quotes that represent the fair value of a specific security. The review confirms that the pricing service is utilizing information from observable transactions or a technique that represents a market participant’s assumptions. The Company does not adjust quotes received from the pricing service. The pricing service utilized by The Company has indicated that they will only produce an estimate of fair value if there is objectively verifiable information available.
The Company holds a small amount of private placement debt and available-for-sale fixed maturity securities that have characteristics that make them unsuitable for matrix pricing. For these securities, a quote from an independent pricing source (typically a market maker) is obtained. Due to the disclaimers on the quotes that indicate the price is indicative only, the Company includes these fair value estimates in Level 3.
For securities priced using a quote from an independent pricing source, such as the equity-indexed options and certain available-for-sale fixed maturity securities, the Company uses a market-based fair value analysis to validate the reasonableness of prices received. Price variances above a certain threshold are analyzed further to determine if any pricing issue exists. This analysis is performed quarterly.
Equity Securities — For publicly-traded equity securities, prices are received from a nationally recognized pricing service that are based on observable market transactions, and these securities are classified as Level 1 measurements. For certain preferred stock, current market quotes in active markets are unavailable. In these instances, an estimated fair value is received from the pricing service. The service utilizes similar methodologies to price preferred stocks as it does for available-for-sale fixed maturity securities. If applicable, these estimates would be disclosed as Level 2 measurements. The Company tests the accuracy of the information provided by reference to other services annually. For certain private equity without readily determinable fair values, fair value estimates are unavailable and are not disclosed.
Short-term Investments — Short-term investments are primarily commercial paper rated A2 or P2 or better by Standard & Poor’s and Moody’s, respectively. Commercial paper is carried at amortized cost which approximates fair value. These investments are classified as Level 2 measurements.
Real estate and Real Estate Partnerships — The fair values of residential real estate investments held through consolidation of investment company VIEs are initially recorded based on the cost to purchase the properties and subsequently recorded at fair value on a recurring basis and falls within Level 3 of the fair value hierarchy. The fair value of the residential real estate properties was determined using broker price opinions (BPOs). A BPO is an appraisal methodology commonly used in the industry to estimate net proceeds from the sale of a home. The significant inputs into the valuation include market comparable home sales, age and size of the home, location and property conditions.
Two of our consolidated variable interest entities, which are fair valued on a recurring basis, invest in limited liability companies that invest in operating entities which hold multifamily real estate properties. The fair value of the limited liability companies was obtained from a third party and is based on the fair value of the underlying real estate held by the various operating entities. The real estate is initially calculated based on the cost to purchase the properties and subsequently calculated based on a discounted cash flow methodology.
Investment Funds — We own an investment in an infrastructure limited liability company through a consolidated VIE that is measured at fair value on a recurring basis. We initially recorded the investment at the cost to purchase the investment and subsequently recorded based on a discounted cash flow methodology. We own one consolidated limited partnership fund, which is measured using NAV as a practical expedient. This investment is a closed-end fund that invests in infrastructure credit assets. Redemptions are not allowed until the funds’ termination date and liquidations begin.
Cash and Cash Equivalents — Amounts reported in the Consolidated Statements of Financial Position for these instruments are reported at their historical cost which approximates fair value due to the nature of the assets assigned to this category.
Other Invested Assets – The Company holds interest in an investment company limited partnership, which invests in residual interest investments, and is a consolidated VIE. The investment was initially recorded at cost and will subsequently be recorded at fair value using discounted cash flow methodology and falls within Level 3 of the fair value hierarchy.
Separate Account Assets and Liabilities — The separate account assets included on the quantitative disclosures fair value hierarchy table are comprised of short-term investments, equity securities, and available-for-sale fixed maturity. Equity securities are classified as Level 1 measurements. Short-term investments and available-for-sale fixed maturity securities are classified as Level 2 measurements. These classifications for separate account assets reflect the same fair value level methodologies as listed above as they are derived from the same vendors and follow the same process.
The separate account assets also include cash and cash equivalents, investment funds, accrued investment income, and receivables for securities. These are not included in the quantitative disclosures of fair value hierarchy table.
Market Risk Benefits - MRBs are valued using stochastic models that incorporate a spread reflecting our non-performance risk. The key assumptions for calculating the fair value of the MRBs are market assumptions such as equity market returns, interest rate levels, market volatility and correlations and policyholder behavior assumptions such as lapse, mortality, utilization and withdrawal patterns. Risk margins are included in the policyholder behavior assumptions. The assumptions are based on a combination of historical data and actuarial judgment. MRBs are classified as Level 3 fair value measurements as the fair value is based on unobservable inputs. The following significant unobservable inputs are used for measuring the fair value:
(1)Utilization – The utilization assumption represents the percentage of policyholders who will elect to receive lifetime income benefit payments in a given year. The range and weighted average of this assumption can vary from year to year depending on the characteristics of policies in a given cohort within the rate.
(2)Option budget – The option budget assumption represents the expected cost of annual call options we will purchase in the future.
(3)Nonperformance risk – The nonperformance risk assumption impacts the discount rate used in the discounted future cash flow valuation and includes our own credit risk based on the current market credit spreads for debt-like instruments we have issued and are available in the market. Additionally, the nonperformance risk assumption includes the counterparty credit risk used in the fair value measurement of ceded market risk benefits which is determined using the current market credit spreads based on the counterparty credit rating.
(4)Mortality rates – The mortality rate assumptions are set based on a combination of company and industry experience, adjusted for improvement factors. Mortality rates vary by age and by demographic characteristics such as gender.
(5)Lapse rates – The lapse rate assumptions represent the expected rate of full surrenders which are set based on product type or feature and whether a policy is subject to surrender charges.
Derivative Assets/Derivative Liabilities
Equity-index options —Equity index options are valued using industry accepted valuation models and are adjusted for the nonperformance risk of each counterparty net of any collateral held. Inputs include market volatility and risk free interest rates and are used in income valuation techniques in arriving at a fair value for each option contract. The nonperformance risk for each counterparty is based upon its credit default swap rate. We have no performance obligations related to the call options purchased to fund our fixed index annuity policy liabilities.
Policyholders’ Account Balances – Embedded Derivatives —The fair value of the embedded derivative component of our fixed index annuity policyholder account balance reserve is estimated at each valuation date by (i) projecting policy contract values and minimum guaranteed contract values over the expected lives of the contracts and (ii) discounting the excess of the projected contract value amounts at the applicable risk free interest rates adjusted for our nonperformance risk related to those liabilities.
The following significant unobservable inputs are used for measuring the fair value:
(1)Option budget
(2)Lapse rates
(3)Nonperformance risk
The fair value of our fixed index annuities embedded derivatives is net of coinsurance ceded of $1.1 billion as of June 30, 2024. Change in fair value, net for each period in our embedded derivatives is included in Change in fair value of embedded derivatives in the Consolidated Statements of Operations.
Funds Withheld Liabilities —We estimate the fair value of the embedded derivative based on the fair value of the assets supporting the funds withheld payable under modified coinsurance and funds withheld coinsurance reinsurance agreements. The fair value of the embedded derivative is classified as Level 3 based on valuation methods used for the assets held supporting the reinsurance agreements.
Separately Managed Accounts —The separately managed account manager uses the mid-point of a range from a third-party to price these securities. Discounted cash flows (yield analysis) and market transactions approach are used in the valuation. They use discount rates which is considered an unobservable input.
The fair value hierarchy measurements for assets and liabilities measured at fair value on a recurring basis are shown below:
| Assets and Liabilities Carried at Fair Value by Hierarchy Level | ||||
|---|---|---|---|---|
| TotalFair Value | Level 1 | Level 2 | Level 3 | |
| (Dollars in millions) | ||||
| Financial assets | ||||
| Available-for-sale fixed maturity securities: | ||||
| U.S. treasury and government | $83 | $83 | $— | $— |
| U.S. states and political subdivisions | 3,299 | — | 3,047 | 252 |
| Foreign governments | 453 | — | 453 | — |
| Corporate debt securities | 31,949 | — | 29,035 | 2,914 |
| Residential mortgage-backed securities | 1,079 | — | 1,057 | 22 |
| Commercial mortgage-backed securities | 2,766 | — | 2,743 | 23 |
| Collateralized debt securities | 6,851 | — | 3,775 | 3,076 |
| Total fixed maturity, available-for-sale | 46,480 | 83 | 40,110 | 6,287 |
| Equity securities: | ||||
| Common stock | 1,081 | 384 | 2 | 695 |
| Preferred stock | 114 | 23 | — | 91 |
| Private equity and other | 5 | — | — | 5 |
| Total equity securities | 1,200 | 407 | 2 | 791 |
| Real estate at fair value (1) | 1,279 | — | — | 1,279 |
| Real estate partnerships at fair value (1) | 39 | — | — | 39 |
| Investment funds (fair value option) (1)(2) | 111 | — | — | 111 |
| Short-term investments | 1,945 | 823 | 544 | 578 |
| Other invested assets: | ||||
| Derivative assets | 1,610 | — | 1,356 | 254 |
| Collaterals received on derivatives (excluding excess collateral) | (1,587) | (1,587) | — | — |
| Separately managed accounts | 89 | — | — | 89 |
| Other | 425 | — | — | 425 |
| Cash and cash equivalents | 13,895 | 13,895 | — | — |
| Other assets - market risk benefit assets | 704 | — | — | 704 |
| Separate account assets (3) | 1,234 | 200 | 1,034 | — |
| Total financial assets | $67,424 | $13,821 | $43,046 | $10,557 |
| Financial liabilities | ||||
| Policyholders’ account balances – embedded derivative | $1,196 | $— | $— | $1,196 |
| Market risk benefits | 3,276 | — | — | 3,276 |
| Funds withheld liabilities - embedded derivatives | 79 | — | — | 79 |
| Separate account liabilities (3) | 1,234 | 200 | 1,034 | — |
| Total financial liabilities | $5,785 | $200 | $1,034 | $4,551 |
(1)Balances represent financial assets that are fair valued as a result of consolidation of investment company VIE in accordance with ASC 946.
(2)Balance excludes $360 million of investments measured at estimated fair value using NAV as a practical expedient.
(3)Balance includes $32 million of assets, and corresponding liabilities, that are not subject to fair value hierarchy.
| Assets and Liabilities Carried at Fair Value by Hierarchy Level | ||||
|---|---|---|---|---|
| TotalFair Value | Level 1 | Level 2 | Level 3 | |
| (Dollars in millions) | ||||
| Financial assets | ||||
| Available-for-sale fixed maturity securities: | ||||
| U.S. treasury and government | $62 | $62 | $— | $— |
| U.S. states and political subdivisions | 578 | — | 578 | — |
| Foreign governments | 9 | — | 9 | — |
| Corporate debt securities | 10,784 | — | 8,570 | 2,214 |
| Residential mortgage-backed securities | 127 | — | 127 | — |
| Commercial mortgage-backed securities | — | — | — | — |
| Collateralized debt securities | 1,317 | — | 416 | 901 |
| Total fixed maturity, available-for-sale | 12,877 | 62 | 9,700 | 3,115 |
| Equity securities: | ||||
| Common stock | 1,307 | 314 | — | 993 |
| Preferred stock | 97 | 22 | — | 75 |
| Private equity and other | — | — | — | — |
| Total equity securities | 1,404 | 336 | — | 1,068 |
| Real estate at fair value | — | — | — | — |
| Real estate partnerships at fair value | — | — | — | — |
| Investment funds (fair value option) | — | — | — | — |
| Short-term investments | 2,397 | 1,100 | — | 1,297 |
| Other invested assets: | ||||
| Derivative assets | 227 | — | — | 227 |
| Collaterals received on derivatives (excluding excess collateral) | (226) | — | — | (226) |
| Separately managed accounts | 105 | — | — | 105 |
| Other | — | — | — | — |
| Cash and cash equivalents | 3,192 | 3,192 | — | — |
| Other assets - market risk benefit assets | 34 | — | — | 34 |
| Separate account assets (1) | 1,163 | 406 | 757 | — |
| Total financial assets | $21,173 | $5,096 | $10,457 | $5,620 |
| Financial liabilities | ||||
| Policyholders’ account balances – embedded derivative | $873 | $— | $— | $873 |
| Market risk benefits | 34 | — | — | 34 |
| Funds withheld liabilities - embedded derivatives | — | — | — | — |
| Separate account liabilities (1) | 1,163 | 406 | 757 | — |
| Total financial liabilities | $2,070 | $406 | $757 | $907 |
(1)Balance includes $26 million of assets, and corresponding liabilities, that are not subject to fair value hierarchy.
Fair Value Information About Financial Instruments Not Recorded at Fair Value
Information about fair value estimates for financial instruments not measured at fair value is discussed below:
Mortgage Loans— The fair value of mortgage loans is estimated using discounted cash flow analyses on a loan-by-loan basis by applying a discount rate to expected cash flows from future installment and balloon payments. The discount rate takes into account general market trends and specific credit risk trends for the individual loan. Factors used to arrive at the discount rate include inputs from spreads based on U.S. Treasury notes and the loan’s credit quality, region, property-type, lien priority, payment type and current status.
Private Loans— The fair value of private loans is estimated using discounted cash flow analyses on a loan-by-loan basis by applying a discount rate to expected cash flows from future installment and balloon payments. The discount rate takes into account general market trends and specific credit risk trends for the individual loan. For certain of our collateral loans, we have concluded the carrying value approximates fair value.
Policy Loans— The carrying value of policy loans is the outstanding balance plus any accrued interest. Due to the collateralized nature of policy loans such that they cannot be separated from the policy contracts, the unpredictable timing of repayments and the fact that settlement is at outstanding value, as such the carrying value of policy loans approximates fair value.
Long Term Borrowings— Long term borrowings are carried at outstanding principal balance. The carrying value approximates fair value because the carrying value represents the amount owing and payable to the creditor at the reporting date. Fair values for subordinated debentures are estimated using discounted cash flow calculations principally on observable inputs including our incremental borrowing rates, which reflect our credit rating, for similar types of borrowings with maturities consistent with those remaining for the debt being valued.
Notes Payable— Notes payable are carried at outstanding principal balance. For a majority of the notes, the carrying value of the notes payable approximates fair value because the underlying interest rates approximate market rates at the reporting date.
Other Invested Assets— FHLB common stock is carried at cost which approximates fair value. The fair value of our COLI is equal to the cash surrender value of the policies.
Policyholder’s account balances & Reinsurance recoverables and deposit assets— The fair values of the policyholder account balances’ not involving significant mortality or morbidity risks, are stated at the cost we would incur to extinguish the liability (i.e., the cash surrender value) as these contracts are generally issued without an annuitization date. The deposit assets related to the ceded annuity benefit reserves have fair values determined in a similar fashion. For period-certain annuity benefit contracts, the fair value is determined by discounting the benefits at the interest rates currently in effect for newly issued immediate annuity contracts. All of the fair values presented within these categories fall within Level 3 of the fair value hierarchy as most of the inputs are unobservable market data.
The carrying value and estimated fair value of financial instruments not recorded at fair value on a recurring basis are shown below:
| Carrying Amount · Fair Value · Fair Value Hierarchy Level | |||||
|---|---|---|---|---|---|
| Level 1 · Level 2 · Level 3 | |||||
| (Dollars in millions) | |||||
| Financial assets | |||||
| Mortgage loans on real estate, net of allowance | $12,042 | $11,812 | $— | $— | $11,812 |
| Private loans, net of allowance | 1,724 | 1,729 | — | 846 | 883 |
| Policy loans | 401 | 401 | — | — | 401 |
| Deposit assets, included in reinsurance recoverables and deposit assets | 15,261 | 14,196 | — | — | 14,196 |
| Other invested assets | 407 | 407 | — | 403 | 4 |
| Total financial assets | $29,835 | $28,545 | |||
| Financial liabilities | |||||
| Policyholders' account balances, excluding embedded derivative | $76,797 | $76,797 | $— | $— | $76,797 |
| Long term borrowings | 2,476 | 2,458 | — | — | 2,458 |
| Notes payable | 657 | 657 | — | — | 657 |
| Total financial liabilities | $79,930 | $79,912 | |||
| Carrying Amount · Fair Value · Fair Value Hierarchy Level | |||||
| Level 1 · Level 2 · Level 3 | |||||
| (Dollars in millions) | |||||
| Financial assets | |||||
| Mortgage loans on real estate, net of allowance | $5,658 | $5,405 | $— | $— | $5,405 |
| Private loans, net of allowance | 194 | 194 | — | — | 194 |
| Policy loans | 390 | 390 | — | — | 390 |
| Deposit assets, included in reinsurance recoverables and deposit assets | — | — | — | — | — |
| Other invested assets | 14 | 14 | — | — | 14 |
| Total financial assets | $6,256 | $6,003 | |||
| Financial liabilities | |||||
| Policyholders' account balances, excluding embedded derivative | $14,097 | $14,097 | $— | $— | $14,097 |
| Long term borrowings | 1,493 | 1,493 | — | — | 1,493 |
| Notes payable | 174 | 174 | — | — | 174 |
| Total financial liabilities | $15,764 | $15,764 | |||
For financial assets and financial liabilities measured at fair value on a recurring basis using Level 3 inputs during the periods, reconciliations of the beginning and ending balances are shown below:
| Three Months Ended June 30, 2024 | ||||
|---|---|---|---|---|
| Assets · Liabilities | ||||
| InvestedAssets (1) | Derivative Assets | PAB – Embedded Derivative | Funds Withheld for Reinsurance Liabilities - Embedded Derivative | |
| (Dollars in millions) | ||||
| Balance, beginning of period | $5,199 | $257 | $904 | $— |
| Acquisitions from business combination | 4,288 | — | — | — |
| Fair value changes in net income | 12 | 24 | 287 | 79 |
| Net change included in interest sensitive contract benefits | — | — | — | — |
| Fair value changes in other comprehensive income | 875 | — | — | — |
| Purchases | 1,302 | 39 | — | — |
| Sales | (2,048) | — | — | — |
| Settlements or maturities | (2) | (66) | (30) | — |
| Premiums less benefits | — | — | 35 | — |
| Transfers into Level 3 | 112 | — | — | — |
| Transfers out of Level 3 | (139) | — | — | — |
| Balance, end of period | $9,599 | $254 | $1,196 | $79 |
| Three Months Ended June 30, 2023 | ||||
| Assets · Liabilities | ||||
| InvestedAssets (1) | Derivative Assets | PAB – Embedded Derivative | Funds Withheld for Reinsurance Liabilities - Embedded Derivative | |
| (Dollars in millions) | ||||
| Balance, beginning of period | $4,419 | $167 | $784 | $— |
| Acquisitions from business combination | — | — | — | — |
| Fair value changes in net income | 11 | 47 | — | — |
| Net change included in interest sensitive contract benefits | — | — | 51 | — |
| Fair value changes in other comprehensive income | (1) | — | — | — |
| Purchases | 822 | 30 | — | — |
| Sales | (631) | — | — | — |
| Settlements or maturities | — | (29) | — | — |
| Premiums less benefits | — | — | (26) | — |
| Transfers into Level 3 | — | — | — | — |
| Transfers out of Level 3 | — | — | — | — |
| Balance, end of period | $4,620 | $215 | $809 | $— |
| Six Months Ended June 30, 2024 | ||||
|---|---|---|---|---|
| Assets · Liabilities | ||||
| InvestedAssets (1) | Derivative Assets | PAB – Embedded Derivative | Funds Withheld for Reinsurance Liabilities - Embedded Derivative | |
| (Dollars in millions) | ||||
| Balance, beginning of year | $5,585 | $227 | $873 | $— |
| Acquisitions from business combination | 4,288 | — | — | — |
| Fair value changes in net income | 12 | 81 | 287 | 79 |
| Net change included in interest sensitive contract benefits | — | — | (38) | — |
| Fair value changes in other comprehensive income | 182 | — | — | — |
| Purchases | 3,346 | 74 | — | — |
| Sales | (3,785) | — | — | — |
| Settlements or maturities | (2) | (128) | (30) | — |
| Premiums less benefits | — | — | 104 | — |
| Transfers into Level 3 | 112 | — | — | — |
| Transfers out of Level 3 | (139) | — | — | — |
| Balance, end of period | $9,599 | $254 | $1,196 | $79 |
| Six Months Ended June 30, 2023 | ||||
| Assets · Liabilities | ||||
| InvestedAssets (1) | Derivative Assets | PAB – Embedded Derivative | Funds Withheld for Reinsurance Liabilities - Embedded Derivative | |
| (Dollars in millions) | ||||
| Balance, beginning of year | $3,167 | $121 | $726 | $— |
| Acquisitions from business combination | — | — | — | — |
| Fair value changes in net income | 97 | 72 | — | — |
| Net change included in interest sensitive contract benefits | — | — | 102 | — |
| Fair value changes in other comprehensive income | (1) | — | — | — |
| Purchases | 2,235 | 60 | — | — |
| Sales | (878) | — | — | — |
| Settlements or maturities | — | (38) | — | — |
| Premiums less benefits | — | — | (19) | — |
| Transfers into Level 3 | — | — | — | — |
| Transfers out of Level 3 | — | — | — | — |
| Balance, end of period | $4,620 | $215 | $809 | $— |
(1)Balance includes derivative collaterals and separately managed accounts.
Transfers into and out of Level 3 during the three and six months ended June 30, 2024 were primarily the result of changes in observable pricing.
Quantitative Information about Level 3 Fair Value Measurements
The following table provides quantitative information about the significant unobservable inputs used for recurring fair value measurements categorized within Level 3, excluding investments where third party valuation inputs were not reasonably available.
| June 30, 2024 | |||
|---|---|---|---|
| Assets /(Liabilities)Measured atFair Value | ValuationTechniques(s) | UnobservableInputDescription | |
| (Dollars in millions) | |||
| Assets: | |||
| Fixed maturity securities: | |||
| Corporate debt securities | $83 | Discounted cash flow | Liquidity premium |
| Collateralized debt securities | 1,947 | Discounted cash flow | Discount rate |
| Weighted average lives | |||
| Real estate at fair value | 1,279 | Broker price opinion | |
| Real estate partnerships at fair value | 39 | Discounted cash flow | Residual capitalization rate |
| Discount rate | |||
| Investment funds at fair value | 111 | Discounted cash flow | Discount rate |
| Other invested assets - other | 157 | Discounted cash flow | Discount rate |
| Weighted average lives | |||
| Separately managed accounts | 89 | Discounted cash flows (yield analysis) | Discount rate |
| CVM · NCY EBITDA | |||
| Market transaction | |||
| December 31, 2023 | |||
| Assets /(Liabilities)Measured atFair Value | ValuationTechniques(s) | UnobservableInputDescription | |
| (Dollars in millions) | |||
| Assets: | |||
| Separately managed accounts | $105 | Discounted cash flows (yield analysis) | Discount rate |
| CVM · NCY EBITDA | |||
| Market transaction | |||
- Reinsurance
The Company also reinsures its business through a diversified group of reinsurers. The Company remains liable to the extent its reinsurers do not meet their obligations under the reinsurance agreements. The Company monitors trends in arbitration and any litigation outcomes with its reinsurers. Collectability of reinsurance balances is evaluated by monitoring ratings and the financial strength of its reinsurers. The effect of reinsurance on net premiums earned and claims incurred and policyholder benefits paid are as follows:
| Three Months EndedJune 30, | Six Months EndedJune 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (Dollars in millions) | ||||
| Premiums earned: | ||||
| Gross amounts | $1,387 | $1,344 | $2,871 | $2,411 |
| Reinsurance ceded | (382) | (342) | (722) | (628) |
| Net premiums earned | $1,005 | $1,002 | $2,149 | $1,783 |
| Other policy revenue: | ||||
| Gross amounts | $203 | $103 | $315 | $200 |
| Reinsurance ceded | (19) | — | (19) | — |
| Net other policy revenue | $184 | $103 | $296 | $200 |
| Policyholder benefits paid and claims incurred: | ||||
| Gross amounts | $1,296 | $1,171 | $2,588 | $2,029 |
| Reinsurance ceded | (266) | (182) | (472) | (340) |
| Net benefits paid and claims incurred | $1,030 | $989 | $2,116 | $1,689 |
| Change in fair value of market risk benefits: | ||||
| Gross amounts | $148 | $(24) | $186 | $(14) |
| Reinsurance ceded | (9) | 12 | (28) | 7 |
| Net change in fair value of market risk benefits | $139 | $(12) | $158 | $(7) |
| Interest sensitive contract benefits: | ||||
| Gross amounts | $506 | $175 | $765 | $365 |
| Reinsurance ceded | (116) | (59) | (220) | (160) |
| Net interest sensitive contract benefits | $390 | $116 | $545 | $205 |
Annuity
The following summarizes our annuity reinsurance treaties and related recoverable (in millions):
| ReinsuranceRecoverable | Agreement Type | Products Covered | |
|---|---|---|---|
| (Dollars in millions) | |||
| Principal Reinsurers: | |||
| EquiTrust Life Insurance Company | $245 | Coinsurance | Certain Fixed Index and Fixed Rate Annuities |
| Athene Life Re Ltd. | 2,044 | Coinsurance Funds Withheld, Modified Coinsurance | Certain Fixed Annuities and Multi-Year Guaranteed Annuities |
| North End Re (Cayman) SPC | 8,075 | Coinsurance Funds Withheld, Modified Coinsurance | Certain Fixed Annuities |
| AeBe ISA LTD | 4,397 | Coinsurance Funds Withheld, Coinsurance | Certain Fixed Index and Fixed Rate Annuities |
| $14,761 | |||
There were no significant changes to third party reinsurance agreements for the three and six months ended June 30, 2024.
We calculate estimated losses on reinsurance recoverable balances by determining an expected loss ratio. The expected loss ratio is based on industry historical loss experience and expected recovery timing adjusted for certain current and forecasted environmental factors management believes to be relevant. Estimated losses related to our reinsurance recoverable balances was $0 million as of June 30, 2024.
The company incurred risk charge fees of $3 million and $3 million during the three and six months ended June 30, 2024, in relation to reinsurance agreements.
Intercompany Reinsurance Agreements
The Company executes various intercompany reinsurance agreements between its subsidiaries, including off shore entities, for purposes of managing regulatory statutory capital and risk. All intercompany balances have been eliminated in the preparation of the accompanying financial statements.
These intercompany transactions are executed with wholly owned reinsurance subsidiaries, AEL Re Vermont, AEL Re Vermont II, Freestone Re Ltd. (“Freestone”), and AEL Re Bermuda Ltd. The reinsurance agreements with AEL Re Vermont and AEL Re Vermont II involve reinsuring a portion of lifetime income benefit rider payments in excess of policy fund values. These entities then entered into third-party excess of loss agreements which are permitted to be an admitted asset on the statutory balance sheets. The reinsurance agreement with AEL Re Bermuda Ltd. Is a coinsurance agreement to reinsure a portion of fixed index annuities on a funds withheld basis.
Property and Casualty
There were no significant changes to third party reinsurance agreements for the three and six months ended June 30, 2024 and 2023.
- Separate Account Assets and Liabilities
The following table presents the change of the Company’s separate account assets and liabilities:
| Three Months EndedJune 30, | Six Months EndedJune 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (Dollars in millions) | ||||
| Balance, beginning of period | $1,285 | $1,098 | $1,189 | $1,045 |
| Additions (deductions): | ||||
| Acquisition from business combination | — | — | — | — |
| Policyholder deposits | 15 | 18 | 35 | 39 |
| Net investment income | 1 | 5 | 10 | 14 |
| Net realized capital gains on investments | 16 | 62 | 112 | 114 |
| Policyholder benefits and withdrawals | (27) | (35) | (75) | (59) |
| Net transfer from (to) general account | (20) | 1 | 2 | (1) |
| Policy charges | (4) | (4) | (7) | (7) |
| Total changes | (19) | 47 | 77 | 100 |
| Balance, end of period | $1,266 | $1,145 | $1,266 | $1,145 |
- Deferred Policy Acquisition Costs, Deferred Sales Inducements and Value of Business Acquired
The following tables present the balances and changes in DAC, DSI and VOBA by segment:
| Annuity | Life | Property and Casualty | Total | |
|---|---|---|---|---|
| (Dollars in millions) | ||||
| DAC | ||||
| Balance, beginning of period | $223 | $249 | $135 | $607 |
| Additions | 191 | 19 | 85 | 295 |
| Amortization | (8) | 3 | (80) | (85) |
| Net change | 183 | 22 | 5 | 210 |
| Balance, end of period | $406 | $271 | $140 | $817 |
| DSI | ||||
| Balance, beginning of period | $9 | $— | $— | $9 |
| Additions | 93 | — | — | 93 |
| Amortization | 1 | — | — | 1 |
| Net change | 94 | — | — | 94 |
| Balance, end of period | $103 | $— | $— | $103 |
| VOBA | ||||
| Balance, beginning of period | $38 | $300 | $18 | $356 |
| Acquisition from business combinations | 7,194 | — | — | 7,194 |
| Additions | — | — | — | — |
| Amortization | (106) | (7) | (2) | (115) |
| Net change | 7,088 | (7) | (2) | 7,079 |
| Balance, end of period | $7,126 | $293 | $16 | $7,435 |
| Total DAC, DSI, and VOBA Asset | $7,635 | $564 | $156 | $8,355 |
| Annuity | Life | Property and Casualty | Total | |
| (Dollars in millions) | ||||
| DAC | ||||
| Balance, beginning of period | $64 | $131 | $145 | $340 |
| Additions | 66 | 37 | 116 | 219 |
| Amortization | (2) | (6) | (105) | (113) |
| Net change | 64 | 31 | 11 | 106 |
| Balance, end of period | $128 | $162 | $156 | $446 |
| DSI | ||||
| Balance, beginning of period | $5 | $— | $— | $5 |
| Additions | 1 | — | — | 1 |
| Amortization | — | — | — | — |
| Net change | 1 | — | — | 1 |
| Balance, end of period | $6 | $— | $— | $6 |
| VOBA | ||||
| Balance, beginning of period | $43 | $329 | $34 | $406 |
| Acquisition from business combinations | — | — | — | — |
| Additions | — | — | — | — |
| Amortization | — | (8) | (11) | (19) |
| Net change | — | (8) | (11) | (19) |
| Balance, end of period | $43 | $321 | $23 | $387 |
| Total DAC, DSI, and VOBA Asset | $177 | $483 | $179 | $839 |
| Annuity | Life | Property and Casualty | Total | |
|---|---|---|---|---|
| (Dollars in millions) | ||||
| DAC | ||||
| Balance, beginning of period | $190 | $224 | $158 | $572 |
| Additions | 230 | 57 | 196 | 483 |
| Amortization | (14) | (10) | (214) | (238) |
| Net change | 216 | 47 | (18) | 245 |
| Balance, end of period | $406 | $271 | $140 | $817 |
| DSI | ||||
| Balance, beginning of period | $8 | $— | $— | $8 |
| Additions | 94 | — | — | 94 |
| Amortization | 1 | — | — | 1 |
| Net change | 95 | — | — | 95 |
| Balance, end of period | $103 | $— | $— | $103 |
| VOBA | ||||
| Balance, beginning of period | $39 | $305 | $20 | $364 |
| Acquisition from business combinations | 7,194 | — | — | 7,194 |
| Additions | — | — | — | — |
| Amortization | (107) | (12) | (4) | (123) |
| Net change | 7,087 | (12) | (4) | 7,071 |
| Balance, end of period | $7,126 | $293 | $16 | $7,435 |
| Total DAC, DSI, and VOBA Asset | $7,635 | $564 | $156 | $8,355 |
| Annuity | Life | Property and Casualty | Total | |
| (Dollars in millions) | ||||
| DAC | ||||
| Balance, beginning of period | $43 | $88 | $121 | $252 |
| Additions | 90 | 84 | 227 | 401 |
| Amortization | (5) | (10) | (192) | (207) |
| Net change | 85 | 74 | 35 | 194 |
| Balance, end of period | $128 | $162 | $156 | $446 |
| DSI | ||||
| Balance, beginning of period | $4 | $— | $— | $4 |
| Additions | 2 | — | — | 2 |
| Amortization | — | — | — | — |
| Net change | 2 | — | — | 2 |
| Balance, end of period | $6 | $— | $— | $6 |
| VOBA | ||||
| Balance, beginning of period | $44 | $335 | $64 | $443 |
| Acquisition from business combinations | — | — | — | — |
| Additions | — | — | — | — |
| Amortization | (1) | (14) | (41) | (56) |
| Net change | (1) | (14) | (41) | (56) |
| Balance, end of period | $43 | $321 | $23 | $387 |
| Total DAC, DSI, and VOBA Asset | $177 | $483 | $179 | $839 |
Value of Business Acquired
As stated in Note 2 - Summary of Significant Accounting Policies, VOBA asset are included in “Deferred policy acquisition costs, deferred sales inducements and value of business acquired” in the Consolidated Statements of Financial Position. The amortization of VOBA asset is recorded in “Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired” in the Consolidated Statements of Operations.
The following table provides the projected VOBA asset amortization expenses for a five-year period and thereafter:
| Years | (Dollars in millions) |
|---|---|
| 2024 | $317 |
| 2025 | 612 |
| 2026 | 564 |
| 2027 | 514 |
| 2028 | 474 |
| Thereafter | 4,954 |
| Total amortization expense | $7,435 |
- Intangible Assets
The components of definite-lived and indefinite-lived intangible assets are as follows. Refer to Note 14 - Deferred Policy Acquisition Costs, Deferred Sales Inducements and Value of Business Acquired for VOBA asset, which is an actuarial intangible asset arising from a business combination.
| June 30, 2024 | December 31, 2023 | |||||
|---|---|---|---|---|---|---|
| Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | |
| (Dollars in millions) | ||||||
| Definite-lived intangible assets: | ||||||
| Distributor relationships | $1,485 | $(11) | $1,474 | $5 | $— | $5 |
| Trade name | 58 | (3) | 55 | 10 | (2) | 8 |
| Internally generated software | 38 | (1) | 37 | — | — | — |
| Sublease and other | — | — | — | — | — | — |
| Total definite-lived intangible assets | 1,581 | (15) | 1,566 | 15 | (2) | 13 |
| Indefinite-lived intangible assets: | ||||||
| Insurance licenses | 46 | — | 46 | 31 | — | 31 |
| Total indefinite-lived intangible assets | 46 | — | 46 | 31 | — | 31 |
| Total intangible assets | $1,627 | $(15) | $1,612 | $46 | $(2) | $44 |
No impairment expenses of intangible assets were recognized for the three and six months ended June 30, 2024 and 2023. We estimate that our intangible assets do not have any significant residual value in determining their amortization. Amortization expenses for definite-lived intangible assets were $12 million and $13 million for the three and six months ended June 30, 2024 and $0 million and $1 million for the three and six months ended June 30, 2023, respectively.
The following table outlines the estimated future amortization expense related to definite-lived intangible assets held as of June 30, 2024.
| Years | (Dollars in millions) |
|---|---|
| 2024 | $36 |
| 2025 | 73 |
| 2026 | 73 |
| 2027 | 73 |
| 2028 | 73 |
| Thereafter | 1,238 |
| Total amortization expense | $1,566 |
- Acquisitions
On May 2, 2024, in conjunction with the Merger, Brookfield Reinsurance indirectly acquired all of AEL’s issued and outstanding common stock not already owned for a consideration of approximately $2.5 billion in cash and 28,803,599 shares of class A limited voting shares of BAM (“BAM Shares”).
Accounting for the Merger is not finalized, and there remains some measurement uncertainty on the acquisition valuation, which is pending completion of a comprehensive evaluation of the net assets acquired within the next twelve months, including but not limited to identifiable intangible assets, deferred income tax assets, and policyholders’ account balances. The financial statements as of June 30, 2024 reflect management’s current best estimate of the purchase price allocation. Final valuation of the assets acquired and liabilities assumed and the completion of the purchase price allocation will occur by the second quarter of 2025. As a result, the excess of the purchase price over the fair value of net assets acquired, representing goodwill of $630 million as of June 30, 2024 may be adjusted in future periods. Goodwill recognized is not deductible for income tax purposes. In conjunction with the Merger and Post-Effective Merger, Brookfield Reinsurance agreed to indemnify ANGI for certain liabilities that could arise as a result of merger-related activities, including tax liabilities.
Following the Merger, on May 7, 2024, American National and AEL completed the Post-Effective Merger and subsequent Reincorporation. The Post-Effective Merger has been accounted for as a common control transaction as if the parent, American National, acquired the shares of its subsidiary, AEL, similar to that of a reverse acquisition without a change in basis for the assets acquired and liabilities assumed. American National is therefore regarded as the predecessor reporting entity from an accounting perspective even though AEL is the surviving legal entity.
The business operations of AEL, which are now part of ANGI, contributed revenues of $564 million and a net loss of $15 million to the Company for the period from May 2, 2024 to June 30, 2024. Had the Merger occurred on January 1, 2023, the consolidated unaudited pro forma revenue and net profit would be (i) $3.1 billion and $610 million, respectively, for the three months ended June 30, 2024; (ii) $7.0 billion and $1.8 billion, respectively, for the six months ended June 30, 2024; (iii) $2.7 billion and $401 million loss, respectively, for the three months ended June 30, 2023; and (iv) $4.5 billion and $349 million, respectively, for the six months ended June 30, 2023. The pro forma amounts have been calculated using the subsidiary’s results and adjusting them for the revised depreciation and amortization that would have been charged assuming the fair value adjustments to investments, property and equipment and intangible assets had applied from January 1, 2023, together with the consequential tax effects.
The following summarizes the consideration transferred, fair value of assets acquired and liabilities assumed as of the acquisition date:
| (Dollars in millions) | |
|---|---|
| Fair value of consideration transferred: | |
| Cash | $2,525 |
| BAM Shares transferred by the Company | 1,111 |
| Fair value of the Company’s pre-existing interest in AEL | 897 |
| Total consideration | $4,533 |
| Assets acquired: | |
| Investments | $42,960 |
| Cash and cash equivalents | 13,367 |
| Accrued investment income | 414 |
| Value of business acquired | 7,194 |
| Reinsurance recoverables and deposit assets | 14,963 |
| Property and equipment | 42 |
| Intangible assets | 1,580 |
| Other assets | 670 |
| Total assets acquired | $81,190 |
| Liabilities assumed: | |
| Future policy benefits | $310 |
| Policyholders’ account balances | 61,473 |
| Market risk benefits | 2,978 |
| Notes payable | 768 |
| Subsidiary borrowings | 84 |
| Funds withheld for reinsurance liabilities | 8,601 |
| Other liabilities | 2,360 |
| Total liabilities assumed | 76,574 |
| Less: Fair value of AEL preferred stock | 685 |
| Less: Non-controlling interest | 28 |
| Net assets acquired | 3,903 |
| Goodwill | $630 |
Acquisition-related costs of $126 million incurred were recorded as “Operating expenses” in the Consolidated Statements of Operations.
- Future Policy Benefits
The reconciliation of the balances described in the table below to the “Future policy benefits” in the Consolidated Statements of Financial Position is as follows.
| June 30, 2024 | December 31, 2023 | |
|---|---|---|
| (Dollars in millions) | ||
| Future policy benefits: | ||
| Annuity | $3,385 | $2,213 |
| Life | 1,864 | 1,895 |
| Deferred profit liability: | ||
| Annuity | 72 | 64 |
| Life | 83 | 66 |
| Other contracts and VOBA liability | 1,823 | 1,870 |
| Total future policy benefits | $7,227 | $6,108 |
Future Policy Benefits
The balances and changes in the liability for future policy benefits are as follows:
| Six Months EndedJune 30, 2024 · Year EndedDecember 31, 2023 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Annuity · Life · Total · Annuity · Life · Total | ||||||||
| (Dollars in millions) | ||||||||
| Present Value of Expected Net Premiums: | ||||||||
| Balance, beginning of period | $— | $3,145 | $3,145 | $— | $3,520 | $3,520 | ||
| Beginning balance at original discount rate | — | 3,254 | 3,254 | — | 3,826 | 3,826 | ||
| Effect of changes in cash flow assumptions | — | (63) | (63) | — | (353) | (353) | ||
| Effect of actual variances from expected experience | 6 | (34) | (28) | 2 | (59) | (57) | ||
| Adjusted beginning of period balance | 6 | 3,157 | 3,163 | 2 | 3,414 | 3,416 | ||
| Acquisition from business combination | — | — | — | — | — | — | ||
| Issuances | 991 | 32 | 1,023 | 984 | 90 | 1,074 | ||
| Interest accrual | 6 | 62 | 68 | 8 | 121 | 129 | ||
| Net premiums collected | (1,004) | (162) | (1,166) | (995) | (373) | (1,368) | ||
| Derecognitions (lapses and withdrawals) | — | 1 | 1 | 1 | 2 | 3 | ||
| Foreign currency translation | — | — | — | — | — | — | ||
| Ending balance at original discount rate | (1) | 3,090 | 3,089 | — | 3,254 | 3,254 | ||
| Effect of changes in discount rate assumptions | — | (235) | (235) | — | (109) | (109) | ||
| Balance, end of period | $(1) | $2,855 | $2,854 | $— | $3,145 | $3,145 | ||
| Present Value of Expected Future Policy Benefits: | ||||||||
| Balance, beginning of period | $2,213 | $5,040 | $7,253 | $1,288 | $5,330 | $6,618 | ||
| Beginning balance at original discount rate | 2,217 | 5,277 | 7,494 | 1,368 | 5,875 | 7,243 | ||
| Effect of changes in cash flow assumptions | 1 | 74 | 75 | (1) | (362) | (363) | ||
| Effect of actual variances from expected experience | 6 | (33) | (27) | (25) | (59) | (84) | ||
| Adjusted beginning of period balance | 2,224 | 5,318 | 7,542 | 1,342 | 5,454 | 6,796 | ||
| Acquisition of business combination | 311 | — | 311 | — | — | — | ||
| Issuances | 1,003 | 32 | 1,035 | 988 | 89 | 1,077 | ||
| Interest accrual | 71 | 101 | 172 | 73 | 188 | 261 | ||
| Benefit payments | (135) | (228) | (363) | (189) | (456) | (645) | ||
| Derecognitions (lapses and withdrawals) | 1 | 1 | 2 | 3 | 2 | 5 | ||
| Foreign currency translation | — | — | — | — | — | — | ||
| Ending balance at original discount rate | 3,475 | 5,224 | 8,699 | 2,217 | 5,277 | 7,494 | ||
| Effect of changes in discount rate assumptions | (91) | (505) | (596) | (4) | (237) | (241) | ||
| Effect of foreign currency translation on the effect of changes in discount rate assumptions | — | — | — | — | — | — | ||
| Balance, end of period | $3,384 | $4,719 | $8,103 | $2,213 | $5,040 | $7,253 | ||
| Net liability for future policy benefits | $3,385 | $1,864 | $5,249 | $2,213 | $1,895 | $4,108 | ||
| Less: Reinsurance recoverables | (3) | (46) | (49) | — | (45) | (45) | ||
| Net liability for future policy benefits, after reinsurance recoverable | $3,382 | $1,818 | $5,200 | $2,213 | $1,850 | $4,063 | ||
| Weighted-average liability duration of future policy benefits (years) | 8 | 16 | 8 | 16 | ||||
| Weighted average interest accretion rate | 5.09% | 4.61% | 4.94% | 4.60% | ||||
| Weighted average current discount rate | 5.47% | 5.58% | 4.88% | 5.03% | ||||
The amounts of undiscounted and discounted expected gross premiums and future benefit payments follow:
| June 30, 2024 | December 31, 2023 | |||
|---|---|---|---|---|
| Undiscounted | Discounted | Undiscounted | Discounted | |
| (Dollars in millions) | ||||
| Annuity | ||||
| Expected future benefit payments | $5,531 | $3,384 | $3,466 | $2,213 |
| Expected future gross premiums | — | — | — | — |
| Life | ||||
| Expected future benefit payments | 10,375 | 4,719 | 10,353 | 5,040 |
| Expected future gross premiums | 14,649 | 8,507 | 7,541 | 4,328 |
| Total | ||||
| Expected future benefit payments | 15,906 | 8,103 | 13,819 | 7,253 |
| Expected future gross premiums | 14,649 | 8,507 | 7,541 | 4,328 |
The amount of revenue and interest recognized in the Consolidated Statements of Operations follows:
| Six Months EndedJune 30, 2024 | Year EndedDecember 31, 2023 | |||
|---|---|---|---|---|
| Gross Premiumsor Assessments | InterestExpense | Gross Premiumsor Assessments | InterestExpense | |
| (Dollars in millions) | ||||
| Annuity | $1,555 | $81 | $1,027 | $83 |
| Life | 391 | 72 | 452 | 95 |
- Policyholders' Account Balances
Policyholders’ account balances relate to investment-type contracts and universal life-type policies. Investment-type contracts principally include traditional individual fixed annuities and fixed index annuities in the accumulation phase and non-variable group annuity contracts.
The balances and changes in policyholders’ account balances follow.
| Six Months Ended June 30, 2024 | Year EndedDecember 31, 2023 | |||
|---|---|---|---|---|
| Annuity | Life | Annuity | Life | |
| (Dollars in millions) | ||||
| Balance, beginning of period | $14,694 | $1,975 | $12,012 | $1,899 |
| Issuances | 4,064 | 36 | 4,382 | 84 |
| Acquisition from business combination | 61,296 | — | — | — |
| Premiums received | 23 | 213 | 34 | 399 |
| Policy charges | (122) | (187) | (39) | (362) |
| Surrenders and withdrawals | (3,060) | (43) | (2,132) | (110) |
| Interest credited | 707 | 48 | 437 | 65 |
| Benefit payments | (152) | — | — | — |
| Other | 3 | — | — | — |
| Balance, end of period | $77,453 | $2,042 | $14,694 | $1,975 |
| Reconciling items: | ||||
| Supplemental contracts | $489 | $— | $291 | $— |
| Variable universal life | — | 39 | — | 36 |
| Variable deferred annuity | 8 | — | 8 | — |
| Other | 408 | 50 | 135 | 38 |
| Total PAB balance, end of period | $78,358 | $2,131 | $15,128 | $2,049 |
| Weighted-average crediting rate | 2.88% | 4.78% | 3.27% | 3.34% |
| Net amount at risk (a) | $12,466 | $38,365 | $417 | $38,365 |
| Cash surrender value | $71,450 | $1,796 | $15,000 | $1,796 |
(a)Net amount at risk is defined as the current guarantee amount in excess of the current account balance.
The balance of account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimums follow.
| June 30, 2024 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Range ofGuaranteed MinimumCrediting Rate · At Guaranteed Minimum · 1 - 50 Basis Points Above · 51 - 150 Basis Points Above · > 150 Basis Points Above · Other · Total | |||||||||||||
| (Dollars in millions) | |||||||||||||
| Annuity | 0% - 1% | $4,296 | $2,670 | $3,931 | $4,679 | $— | $15,576 | ||||||
| 1% - 2% | 1,446 | 393 | 1,740 | 1,844 | — | 5,423 | |||||||
| 2% - 3% | 1,942 | 429 | 111 | 6,637 | — | 9,119 | |||||||
| Greater than 3% | 306 | 7 | 1 | 5 | — | 319 | |||||||
| Products with either a fixed rate or no guaranteed minimum crediting rate | — | — | — | — | 47,016 | 47,016 | |||||||
| Total | $7,990 | $3,499 | $5,783 | $13,165 | $47,016 | $77,453 | |||||||
| Life | 0% - 1% | $— | $— | $— | $— | $— | $— | ||||||
| 1% - 2% | 34 | 2 | 54 | 667 | — | 757 | |||||||
| 2% to 3% | 421 | — | 222 | — | — | 643 | |||||||
| Greater than 3% | 642 | — | — | — | — | 642 | |||||||
| Products with either a fixed rate or no guaranteed minimum crediting rate | — | — | — | — | — | — | |||||||
| Total | $1,097 | $2 | $276 | $667 | $— | $2,042 | |||||||
| December 31, 2023 | |||||||||||||
| Range ofGuaranteed MinimumCrediting Rate · At Guaranteed Minimum · 1 - 50 Basis Points Above · 51 - 150 Basis Points Above · > 150 Basis Points Above · Other · Total | |||||||||||||
| (Dollars in millions) | |||||||||||||
| Annuity | 0% - 1% | $2,485 | $29 | $483 | $722 | $— | $3,719 | ||||||
| 1% - 2% | 668 | 430 | 1,943 | 2,137 | — | 5,178 | |||||||
| 2% - 3% | 827 | 409 | 56 | 4,224 | — | 5,516 | |||||||
| Greater than 3% | 264 | 7 | 1 | 1 | — | 273 | |||||||
| Products with either a fixed rate or no guaranteed minimum crediting rate | — | — | — | — | 8 | 8 | |||||||
| Total | $4,244 | $875 | $2,483 | $7,084 | $8 | $14,694 | |||||||
| Life | 0% - 1% | $— | $— | $— | $— | $— | $— | ||||||
| 1% - 2% | 168 | 2 | 140 | 371 | — | 681 | |||||||
| 2% to 3% | 415 | — | 219 | — | — | 634 | |||||||
| Greater than 3% | 659 | — | — | — | — | 659 | |||||||
| Products with either a fixed rate or no guaranteed minimum crediting rate | — | — | — | — | 1 | 1 | |||||||
| Total | $1,242 | $2 | $359 | $371 | $1 | $1,975 | |||||||
- Market Risk Benefits
Market Risk Benefits
The balances of and changes in the net market risk benefit (MRB) assets and liabilities for the six months ended June 30, 2024 and year ended December 31, 2023 is as follows:
| Six Months EndedJune 30, 2024 | Year EndedDecember 31, 2023 | |
|---|---|---|
| Annuity | Annuity | |
| (Dollars in millions) | ||
| Balance, beginning of period | $— | $44 |
| Balance, beginning of period, before effect of changes in the instrument-specific credit risk | 1 | 70 |
| Acquisition from business combination | 2,376 | — |
| Issuances | 3 | 1 |
| Interest accrual | 21 | 3 |
| Attributed fees collected | 39 | 13 |
| Benefits payments | — | — |
| Effect of changes in interest rates | 138 | (117) |
| Effect of changes in equity markets | (15) | 171 |
| Effect of changes in equity index volatility | (2) | (46) |
| Actual policyholder behavior different from expected behavior | — | (7) |
| Effect of changes in future expected policyholder behavior | (8) | — |
| Effect of changes in other future expected assumptions | 27 | (87) |
| Balance, end of period, before effect of changes in the instrument-specific credit | 2,580 | 1 |
| Effect of changes in the ending instrument-specific credit risk | (8) | (1) |
| Balance, end of period | 2,572 | — |
| Less: Reinsured MRB, end of period | (618) | — |
| Balance, end of period, net of reinsurance | $1,954 | $— |
| Net amount at risk (a) | $12,051 | $— |
| Weighted average attained age of contract holders (years) | 71 | 65 |
(a)Net amount at risk is defined as the current guarantee amount in excess of the current account balance.
The following is a reconciliation of market risk benefits by amounts in an asset position and in a liability position to “Market risk benefits” amount in the Consolidated Statements of Financial Position:
| June 30, 2024 | |||
|---|---|---|---|
| Asset | Liability | Net Liability | |
| (Dollars in millions) | |||
| Annuity | $704 | $3,276 | $2,572 |
| Total | $704 | $3,276 | $2,572 |
| December 31, 2023 | |||
| Asset | Liability | Net Liability | |
| (Dollars in millions) | |||
| Annuity | $34 | $34 | $— |
| Total | $34 | $34 | $— |
- Liability For Unpaid Claims and Claim Adjustment Expenses
The liability for unpaid claims and claim adjustment expenses (“unpaid claims”) for property and casualty insurance is included in “Policy and contract claims” in the Consolidated Statements of Financial Position and is the amount estimated for incurred but not reported (“IBNR”) claims and claims that have been reported but not settled (“case reserves”), as well as associated claim adjustment expenses.
Information regarding the liability for unpaid claims is shown below:
| Three Months EndedJune 30, | Six Months EndedJune 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (Dollars in millions) | ||||
| Policy and contract claims, beginning | $1,854 | $1,825 | $1,870 | $1,786 |
| Less: Unpaid claims balance, beginning – long-duration | 203 | 250 | 213 | 231 |
| Gross unpaid claims balance, beginning – short-duration | 1,651 | 1,575 | 1,657 | 1,555 |
| Less: Reinsurance recoverables, beginning | 306 | 300 | 302 | 305 |
| Less: Foreign currency translation and other | — | — | — | — |
| Net unpaid claims balance, beginning – short-duration | 1,345 | 1,275 | 1,355 | 1,250 |
| Acquisition from business combination, net of reinsurance | 1 | — | 1 | — |
| Add: incurred related to: | ||||
| Current accident year | 407 | 442 | 750 | 816 |
| Prior accident years | (14) | (11) | (32) | (22) |
| Total incurred claims | 393 | 431 | 718 | 794 |
| Less: paid claims related to: | ||||
| Current accident year | 201 | 234 | 309 | 342 |
| Prior accident years | 142 | 118 | 369 | 348 |
| Total paid claims | 343 | 352 | 678 | 690 |
| Net unpaid claims balance, ending – short-duration | 1,396 | 1,354 | 1,396 | 1,354 |
| Add: Foreign currency translation and other | — | — | — | — |
| Add: Reinsurance recoverables, ending | 271 | 303 | 271 | 303 |
| Gross unpaid claims balance, ending – short-duration | 1,667 | 1,657 | 1,667 | 1,657 |
| Add: Unpaid claims balance, ending – long duration | 213 | 210 | 213 | 210 |
| Policy and contract claims, ending | $1,880 | $1,867 | $1,880 | $1,867 |
The estimates for ultimate incurred claims attributable to insured events of prior years decreased by approximately $14 million and $32 million, respectively, for the three and six months ended June 30, 2024 and decreased $11 million and $22 million, respectively, for the three and six months ended June 30, 2023. The favorable development in 2024 was a reflection of lower-than-anticipated losses arising from commercial other, business owners, and commercial auto lines of business. The favorable development in 2023 was a reflection of lower-than-anticipated losses arising from agribusiness, business owners, commercial auto, and commercial other lines of business.
For short-duration health insurance claims, the total of IBNR plus expected development on reported claims included in the liability for unpaid claims as of June 30, 2024 and December 31, 2023 were $8 million and $4 million, respectively.
- Notes Payable and Long Term Borrowings
On June 16, 2017, the Company issued $500 million aggregate principal amount of senior unsecured notes due 2027 which bear interest at 5.0% per year and will mature on June 15, 2027. Contractual interest is payable semi-annually in arrears each June 15th and December 15th.
On February 15, 2022, the Company entered into afive-year, $300 million unsecured delayed draw term loan credit agreement. On July 6, 2022, we borrowed $300 million under this agreement. Interest was tied to Secured Overnight Financing Rate (“SOFR”) adjusted for a credit spread. In May 2024, the Company repaid in full all indebtedness and other obligations outstanding under, and terminated, this credit agreement using proceeds of the term loan issued on May 7, 2024 that is summarized below.
On May 25, 2022, the Company assumed a term loan agreement with a consortium of banks providing forfive-year term loans in the aggregate principal amount of $1.5 billion maturing May 23, 2027 (the “Term Loan Agreement”). Interest is tied to SOFR and reset and paid quarterly. On June 13, 2022, the Company repaid $500 million under the Term Loan Agreement, and in May 2024 repaid the remaining $1.0 billion outstanding using proceeds of the term loan issued on May 7, 2024 that is summarized below. The Term Loan Agreement was subsequently terminated.
In June 2022, the Company issued $500 million of 6.144% unsecured Senior Notes maturing June 13, 2032. Interest is payable in arrears on June 13 and December 13 of each year. Such notes were offered under Rule 144A of the Securities Act of 1933, as amended (the “Securities Act”). The proceeds from the Senior Notes were used to repay a portion of the Term Loan Agreement. The outstanding note balance was reduced by $3.9 million in unamortized issuance costs as of June 30, 2024. An interest payment of $15.4 million was made during the three and six months ended June 30, 2024.
On May 7, 2024, the Company entered into a new term loan agreement with $1.9 billion borrowed under the agreement as of June 30, 2024. The term loan will mature on May 25, 2027. Interest on the amount borrowed under the term loan is tied to SOFR plus a margin and is reset and paid quarterly.
The agreements above require the Company and its subsidiaries to maintain minimum net worth covenants. As of June 30, 2024 and December 31, 2023, the Company was in compliance with its financial covenants.
Our wholly-owned subsidiary trust (which is not consolidated) has issued fixed rate and floating rate trust preferred securities and has used the proceeds from these offerings to purchase subordinated debentures from us. We also issued subordinated debentures to the trust in exchange for all of the common securities of the trust. The sole assets of the trust are the subordinated debentures and any interest accrued thereon. The interest payment dates on the subordinated debentures correspond to the distribution dates on the trust preferred securities issued by the trust. The trust preferred securities mature simultaneously with the subordinated debentures. Our obligations under the subordinated debentures and related agreements provide a full and unconditional guarantee of payments due under the trust preferred securities.
Following is a summary of subordinated debt obligations to the trusts at June 30, 2024:
| June 30, 2024 | Interest Rate | Due Date | |
|---|---|---|---|
| (Dollars in millions) | |||
| American Equity Capital Trust II | $84 | 5% | June 1, 2047 |
The principal amount of the subordinated debentures issued by us to American Equity Capital Trust II ("Trust II") is $100 million. These debentures were assigned a fair value of $75 million at the date of issue (based upon an effective yield-to-maturity of 6.8%). The difference between the fair value at the date of issue and the principal amount is being accreted over the life of the debentures. The trust preferred securities issued by Trust II were issued to Iowa Farm Bureau Federation, which owns a majority of FBL Financial Group, Inc. ("FBL"). The consideration received by Trust II in connection with the issuance of its trust preferred securities consisted of fixed income securities of equal value which were issued by FBL.
The following is the maturity by year on long term borrowings:
| Payments Due by Year | ||||||||
|---|---|---|---|---|---|---|---|---|
| Total | UnamortizedDiscount andIssuance Costs | Less Than1 year | 1-2Years | 2-3Years | 3-4Years | 4-5Years | More Than5 Years | |
| (Dollars in millions) | ||||||||
| Long term borrowings | $2,476 | $(24) | $— | $— | $1,900 | $— | $— | $600 |
| Long term borrowings | $1,493 | $(7) | $— | $— | $— | $1,000 | $— | $500 |
- Income Taxes
We file consolidated federal income tax returns that include all of our wholly-owned subsidiaries. Our income tax expense as presented in the consolidated financial statements is summarized as follows:
| Three Months EndedJune 30, | Six Months EndedJune 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (Dollars in millions) | ||||
| Consolidated Statements of Operations: | ||||
| Current income tax | $43 | $8 | $45 | $14 |
| Deferred income tax | (332) | 13 | (305) | 5 |
| Total income tax expense included in Consolidated Statements of Operations | (289) | 21 | (260) | 19 |
| Stockholders’ equity: | ||||
| Expense (benefit) relating to: | ||||
| Changes in other comprehensive income | 137 | (43) | 147 | (101) |
| Total income tax expense included in consolidated financial statements | $(152) | $(22) | $(113) | $(82) |
Income tax expense in the Consolidated Statements of Operations differed from the amount computed at the applicable statutory federal income tax rates of 21% for the three and six months ended June 30, 2024 and 2023 as follows:
| Three Months EndedJune 30, | Six Months EndedJune 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (Dollars in millions) | ||||
| Net income (loss) before income taxes | $(42) | $119 | $101 | $130 |
| Total expected income tax expense at the statutory rate | $(9) | $25 | $21 | $27 |
| Tax effect of: | ||||
| Impact of Bermuda corporate income tax | (292) | — | (292) | — |
| Tax exempt net investment income | — | (1) | (1) | (2) |
| Non-deductible compensation | 16 | 1 | 17 | 1 |
| Other | (4) | (4) | (5) | (7) |
| Total income tax expense (recovery) | $(289) | $21 | $(260) | $19 |
The following table presents a reconciliation of income tax rate from statutory rate to effective rate:
| Three Months EndedJune 30, | Six Months EndedJune 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Statutory income tax rate | 21.0% | 21.0% | 21.0% | 21.0% |
| Increase (reduction) in rate resulting from: | ||||
| Impact of Bermuda corporate income tax | 702.2% | —% | (287.9)% | —% |
| Tax exempt net investment income | 1.2% | (0.7)% | (1.0)% | (1.2)% |
| Non-deductible compensation | (39.6)% | 0.5% | 16.7% | 1.0% |
| Other | 10.4% | (3.3)% | (5.4)% | (6.6)% |
| Effective income tax rate | 695.2% | 17.5% | (256.6)% | 14.2% |
Deferred income tax assets or liabilities are established for temporary differences between the financial reporting amounts and tax bases of assets and liabilities that will result in deductible of taxable amounts, respectively, in future years.
The gross movement on the deferred tax asset is as follows:
| June 30, 2024 | December 31, 2023 | |
|---|---|---|
| (Dollars in millions) | ||
| Deferred tax asset, beginning of year | $291 | $439 |
| Recognized in net (income) loss | 305 | (56) |
| Acquisition from business combination | (212) | — |
| Recognized in equity | (147) | (90) |
| Other | (4) | (2) |
| Deferred tax asset, end of period | $233 | $291 |
The tax effects of temporary differences that give rise to the deferred tax assets and liabilities at June 30, 2024 and December 31, 2023 are as follows:
| June 30, 2024 | December 31, 2023 | |
|---|---|---|
| (Dollars in millions) | ||
| Deferred income tax assets: | ||
| Investments | $1,452 | $260 |
| Amounts due reinsurer | 1,113 | — |
| Policy benefit reserves | — | 138 |
| Net operating loss carryforwards | 309 | 31 |
| Bermuda tax asset | 377 | 35 |
| Other | 29 | — |
| Gross deferred tax assets before valuation allowance | 3,280 | 464 |
| Valuation allowance | (5) | (5) |
| Gross deferred tax assets after valuation allowance | 3,275 | 459 |
| Deferred income tax liabilities: | ||
| VOBA/Intangibles | 1,810 | — |
| Deferred policy acquisition costs | 89 | 81 |
| Policy benefit reserves | 1,086 | — |
| Pension and liability for retirement benefits | 57 | 49 |
| Other | — | 38 |
| Gross deferred tax liabilities | 3,042 | 168 |
| Net deferred income tax asset | $233 | $291 |
The Company, excluding certain of its life company subsidiaries which file a separate tax return, are a party to a tax sharing agreement with a US parent entity, BAMR US Holdings, LLC. In accordance with the agreement, if the Company has taxable income, it pays its share of the consolidated federal income tax liability to its parent. However, if the Company incurs a tax loss, the tax benefit is recovered by decreasing subsequent year’s federal income tax payments to its parent.
The Company evaluates its deferred tax asset based on, among other factors, historical operating results, expectation of future profitability, and the duration of the applicable statutory carryforward periods for tax attributes. Based on the evaluation of the deferred tax asset as of June 30, 2024, the Company determined that the deferred tax asset would be realized within the applicable statutory carryforward.
There were no material income tax contingencies requiring recognition in our consolidated financial statements as of June 30, 2024. Our tax returns are subject to audit by various federal, state and local tax authorities. The Company's income tax returns are subject to examination by the IRS and state tax authorities, generally for three years after they are due or filed, whichever is later.
At June 30, 2024 and December 31, 2023, we had federal net operating losses of $1.5 billion and $134 million, respectively. Federal net operating losses can be carried forward indefinitely. Additionally, at June 30, 2024 and December 31, 2023, we had $3 million and $3 million, respectively, of tax credit carryforwards for federal income tax purposes that can be carried forward for 10 years.
On August 16, 2022, the Inflation Reduction Act (the "Act") was signed into law. The Act included several tax provisions including a corporate alternative minimum tax ("CAMT"). For the year ended December 31, 2024, the Company expects to meet the requirements under which it will be subject to the CAMT. For the six months ended June 30, 2024, current tax expense of $43 million includes a $9 million provision CAMT liability. Under the CAMT, the liability, can be credited against future ordinary income tax liabilities. As such, we recorded an offsetting deferred tax benefit.
Introduction of Pillar Two
The Organization for Economic Cooperation and Development (“OECD”) and its member countries with support from the G20, have proposed the enactment of a global minimum tax of 15% for Multinational Enterprise (“MNE”) groups with global annual revenue of €750 million or more (“Pillar Two”). The Company may become subject to additional income taxes as a result of these proposals, as enacted locally across jurisdictions. The Company’s wholly owned subsidiary, Freestone, is incorporated under the laws of Bermuda and is not required to pay any taxes in Bermuda based upon income or capital gains. However, in December 2023, the Government of Bermuda enacted a corporate income tax (“CIT”) regime, designed to align with the OECD’s global minimum tax rules. Effective January 1, 2025, the regime applies a 15% CIT to Bermuda businesses that are part of MNE groups with annual revenue of €750 million or more. As a result of this new regime, the Company recognized a deferred tax benefit of $35 million as of December 31, 2023. In 2024, the Government of Bermuda released further guidance on the calculation and formulation of the CIT. As a result, in 2024, we recorded deferred tax benefits of $292 million (through deferred tax expense) and $50 million (via acquisition accounting for AEL) which increased our Bermuda CIT related deferred tax asset to $377 million. We will continue to monitor developments prior to the commencement of this regime.
- Stockholders' Equity
Prior to the Merger, the Company had one class of common stock with a par value of $1 per share, with 200,000,000 authorized shares and 79,240,903 outstanding shares (excluding 30,583,351 shares of treasury stock). As a result of and following the Merger and the Reincorporation, the Company had 10,000 shares of common stock with a par value of $0.01 per share authorized, of which all are issued and outstanding. See Note 1 - Organization and Description of the Company for additional information.
On November 21, 2019 the Company issued 16,000 shares of 5.95% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series A ("Series A") with a $1.00 par value per share and a liquidation preference of $25,000 per share, for aggregate net proceeds of $389 million.
On June 10, 2020, the Company issued 12,000 shares of 6.625% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series B ("Series B") with a $1.00 par value per share and a liquidation preference of $25,000 per share, for aggregate net proceeds of $290 million.
Dividends on the Series A and Series B preferred stock are payable on a non-cumulative basis only when, as and if declared, quarterly in arrears on the first day of March, June, September and December of each year, commencing on March 1, 2020 for Series A and on December 1, 2020 for Series B. For the three months ended June 30, 2024, we paid dividends totaling $6 million for Series A preferred stock and $5 million for Series B preferred stock, respectively. The Series A and Series B preferred stock are not subject to any mandatory redemption, sinking fund, retirement fund, purchase fund or similar provisions.
- Accumulated Other Comprehensive Income
The components of and changes in the accumulated other comprehensive income (“AOCI”), and the related tax effects, are shown below:
| Change inNet UnrealizedInvestmentGains (Losses) | Change inDiscount Ratefor FuturePolicy Benefits | Change inInstrument-Specific Credit Riskfor MarketRisk Benefit | DefinedBenefitPensionPlanAdjustment | ForeignCurrencyTranslation /Other | Total | |
|---|---|---|---|---|---|---|
| (Dollars in millions) | ||||||
| Balance as of January 1, 2024 | $(299) | $105 | $1 | $85 | $(1) | $(109) |
| Other comprehensive income (loss) before reclassifications | (56) | 128 | (11) | 5 | (3) | 63 |
| Amounts reclassified to (from) AOCI | — | — | — | — | — | — |
| Deferred income tax benefit (expense) | 12 | (26) | 2 | (1) | — | (13) |
| Balance at March 31, 2024 | (343) | 207 | (8) | 89 | (4) | (59) |
| Other comprehensive income (loss) before reclassifications | 489 | 101 | 18 | 19 | 10 | 637 |
| Amounts reclassified to (from) AOCI | 4 | — | — | — | — | 4 |
| Deferred income tax benefit (expense) | (106) | (21) | (4) | (4) | (2) | (137) |
| Balance at June 30, 2024 | $44 | $287 | $6 | $104 | $4 | $445 |
| Balance as of January 1, 2023 | $(722) | $253 | $21 | $1 | $(1) | $(448) |
| Other comprehensive income (loss) before reclassifications | 261 | (106) | (7) | 3 | — | 151 |
| Amounts reclassified to (from) AOCI | 20 | — | — | — | — | 20 |
| Deferred income tax benefit (expense) and other | 59 | — | — | (1) | — | 58 |
| Balance at March 31, 2023 | (382) | 147 | 14 | 3 | (1) | (219) |
| Other comprehensive income (loss) before reclassifications | (269) | 63 | (8) | 4 | — | (210) |
| Amounts reclassified to (from) AOCI | 10 | — | — | (2) | — | 8 |
| Deferred income tax benefit (expense) | 43 | — | — | — | — | 43 |
| Balance at June 30, 2023 | $(598) | $210 | $6 | $5 | $(1) | $(378) |
- Statutory Financial Information and Dividend Restrictions
The Company’s U.S. insurance subsidiaries prepare financial statements in accordance with statutory accounting practices prescribed or permitted by the insurance department of each subsidiary's state of domicile, which include certain components of the National Association of Insurance Commissioners ("NAIC") Statutory Accounting Principles ("SAP"). NAIC SAP is intended to standardize regulatory accounting and reporting to state insurance departments. However, statutory accounting practices continue to be established by individual state laws and permitted practices. Modifications by the various state insurance departments may impact the statutory capital and surplus of our insurance subsidiaries.
Statutory accounting differs from GAAP primarily by charging policy acquisition costs to expense as incurred, establishing future policy benefit liabilities using different actuarial assumptions, and valuing securities on a different basis. In addition, certain assets are not admitted under statutory accounting principles and are charged directly to surplus.
The Company’s non-U.S. insurance subsidiaries which include AEL Re Bermuda and Freestone file financial statements with their respective regulators.
Our U.S. insurance subsidiaries are subject to certain Risk Based Capital (“RBC”) requirements as defined by the National Association of Insurance Commissioners ("NAIC"). RBC requirements require a certain amount of capital and surplus to be maintained based upon various risk factors of the insurance company. Our insurance subsidiaries met the minimum regulatory requirements.
The statutory capital and surplus and net income (loss) of our primary life and property and casualty insurance entities in accordance with statutory accounting practices are shown below (in millions):
| June 30, 2024 | December 31, 2023 | |
|---|---|---|
| (Dollars in millions) | ||
| Statutory capital and surplus: | ||
| American Equity Investment Life Insurance Company | $3,300 | |
| ANG Life insurance entities | 2,777 | $2,776 |
| ANG Property and casualty insurance entities | 1,693 | 1,702 |
| Three Months EndedJune 30, | Six Months EndedJune 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (Dollars in millions) | ||||
| Statutory net income (loss): | ||||
| American Equity Investment Life Insurance Company | $185 | |||
| ANG Life insurance entities | 52 | $(124) | $(13) | $(108) |
| ANG Property and casualty insurance entities | (38) | (47) | 7 | (48) |
American Equity Investment Life Insurance Company (AEILIC) is domiciled in the State of Iowa and is regulated by the Iowa Insurance Division. AEILIC uses prescribed statutory accounting practice which allows for call option derivatives instruments hedging the interest credited on fixed indexed annuities to be recorded at amortized cost and the related fixed index annuity reserve to account for the next index crediting term to be valued at zero. The use of the prescribed statutory accounting practice resulted in lower statutory capital and surplus of $195 million as of June 30, 2024.
AEILIC cedes certain lifetime income benefit rider payments in excess of the policyholder’s account balances to two subsidiaries in Vermont, AEL Re Vermont and AEL Re Vermont II. The Vermont subsidiaries have been granted permitted practices from the Vermont Department to recognize as an admitted asset an excess of loss reinsurance agreement with a third party which reinsures the lifetime income benefit rider payments in excess of policyholder funds values upon exhaustion of a funds withheld account balance. The permitted practice increase the statutory capital of AEL by $3.2 billion at June 30, 2024. Without such permitted practices, the risk based capital at the Vermont entities would fall below the minimum regulatory requirements.
American National has been granted a permitted practice from the Texas Department of Insurance to recognize an admitted asset related to the notional value of coverage defined in an excess of loss reinsurance agreement. The permitted practice increases the statutory capital and surplus of American National by $548 million and $548 million at June 30, 2024 and December 31, 2023, respectively. The statutory capital and surplus of American National would have remained above authorized control level RBC had it not used the permitted practice.
One of American National’s insurance subsidiaries has been granted a permitted practice from the Missouri Department of Insurance to record as the valuation of its investment in a wholly-owned subsidiary that is the attorney-in-fact for a Texas domiciled insurer, the statutory capital and surplus of the Texas domiciled insurer. This permitted practice increases the statutory capital and surplus of American National Property And Casualty Company ("ANPAC") by $63 million and $71 million at June 30, 2024 and December 31, 2023, respectively. The statutory capital and surplus of both ANPAC and American National Lloyds Insurance Company would have remained above the authorized control level RBC had it not used the permitted practice.
- Related Party Transactions
The Company has entered into recurring transactions and agreements with certain related parties. The impact on the Consolidated Financial Statements of significant related party transactions is discussed below.
Investment Management
For the three and six months ended June 30, 2024 the Company’s insurance subsidiaries paid investment management fees due to related party arrangements with affiliates of BAM of $32 million and $45 million, respectively. For the three and six months ended June 30, 2023 the Company paid investment management fees of $10 million and $20 million, respectively.
Reinsurance Agreements
AEILIC has a coinsurance agreement with North End Re (Cayman) SPC, a wholly-owned subsidiary Brookfield Reinsurance, to reinsure a portion of fixed indexed annuity product liabilities,70% on a modified coinsurance (“Modco”) basis and 30% on a coinsurance basis. Below is a table showing a summary of the impact of the reinsurance agreement:
| June 30, 2024 | |
|---|---|
| (Dollars in millions) | |
| Total assets | $8,082 |
| Total liabilities | 5,564 |
| Three Months EndedJune 30,2024 | |
| (Dollars in millions) | |
| Net (loss) | $(78) |
Other Related Party Transactions
In 2024, the Company purchased related party investments totaling $1.2 billion. In 2023, the Company purchased related party investments totaling $4.0 billion. Investment transactions with related parties are accounted for in the same manner as those with unrelated parties in the financial statements.
On November 8, 2022 American National and BAMR US Holdings LLC, an indirect wholly-owned subsidiary of Brookfield Reinsurance (“BAMR”), entered into a deposit agreement. The balance at June 30, 2024 and December 31, 2023 was $284 million and $294 million, respectively. The deposit is considered a cash and cash equivalent in the Company's Consolidated Statements of Financial Position as of June 30, 2024.
On August 17, 2023 ANTAC, LLC (a subsidiary of the Company) and BAMR entered into a deposit agreement. The balance at June 30, 2024 and December 31, 2023 was $186 million and $181 million, respectively. The deposit is considered a cash and cash equivalent in the Company's Consolidated Statements of Financial Position as of June 30, 2024.
Freestone deposited $250 million with the Brookfield Treasury Management Inc. This amount is included in cash and cash equivalents in the Company's Consolidated Statements of Financial Position. For the three and six months ended June 30, 2024, the Company earned interest income of $2 million.
- Segment Reporting
Management organizes the business into four operating segments:
Life - consists of whole, term, universal, indexed and variable life insurance. Products are primarily sold through career, multiple-line, and independent agents as well as direct marketing channels.
Annuity - consists of fixed, fixed index, and variable annuity products as well as PRT contracts. Products are primarily sold through independent agents, brokers, and financial institutions, along with multiple-line and career agents.
Property and Casualty - consists of personal, agricultural and targeted commercial coverages and credit-related property insurance. Products are primarily sold through multiple-line and independent agents or managing general agents. There are also small amounts of Health insurance, consisting of Medicare Supplement, stop-loss, other supplemental health products and credit disability insurance. Products are typically distributed through independent agents and managing general underwriters.
Corporate and Other - consists of net investment income from investments and certain expenses not allocated to the insurance segments and revenues and related expenses from non-insurance operations.
All revenues and expenses specifically attributable to policy transactions are recorded directly to the appropriate operating segment. Revenues and expenses not specifically attributable to policy transactions are allocated to each segment as follows:
Recurring income from bonds and mortgage loans is allocated based on the assets allocated to each segment at the average yield available from these assets.
Net investment income from all other assets is allocated to the insurance segments in accordance with the amount of capital allocated to each segment, with the remainder recorded in the Corporate and Other segment.
Expenses are charged to segments through direct identification and allocations based upon various factors.
The results of operations measured as the income before federal income taxes and other items by operating segments are summarized below.
| Three Months Ended June 30, 2024 | |||||
|---|---|---|---|---|---|
| Annuity | Life | Propertyand Casualty | Corporateand Other | Total | |
| (Dollars in millions) | |||||
| Revenues: | |||||
| Net premiums | $446 | $98 | $461 | $— | $1,005 |
| Other policy revenue | 90 | 94 | — | — | 184 |
| Net investment income | 775 | 102 | 47 | — | 924 |
| Investment related gains (losses) | 3 | — | — | (1) | 2 |
| Total revenues | 1,314 | 294 | 508 | (1) | 2,115 |
| Benefits, losses and expenses: | |||||
| Policyholder benefits and claims incurred | 483 | 161 | 386 | — | 1,030 |
| Interest sensitive contract benefits | 364 | 26 | — | — | 390 |
| Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired | 114 | 11 | 74 | — | 199 |
| Change in fair value of insurance-related derivatives and embedded derivatives | 28 | (7) | — | — | 21 |
| Change in fair value of market risk benefits | 139 | — | — | — | 139 |
| Operating expenses | 80 | 62 | 68 | 125 | 335 |
| Interest expense | — | — | — | 43 | 43 |
| Total benefits and expenses | 1,208 | 253 | 528 | 168 | 2,157 |
| Net income (loss) before income taxes | $106 | $41 | $(20) | $(169) | $(42) |
| Three Months Ended June 30, 2023 | |||||
|---|---|---|---|---|---|
| Annuity | Life | Propertyand Casualty | Corporateand Other | Total | |
| (Dollars in millions) | |||||
| Revenues: | |||||
| Net premiums | $400 | $104 | $498 | $— | $1,002 |
| Other policy revenue | 10 | 93 | — | — | 103 |
| Net investment income | 205 | 80 | 47 | 10 | 342 |
| Investment related gains (losses) | — | — | — | 41 | 41 |
| Total revenues | 615 | 277 | 545 | 51 | 1,488 |
| Benefits, losses and expenses: | |||||
| Policyholder benefits and claims incurred | 414 | 151 | 424 | — | 989 |
| Interest sensitive contract benefits | 65 | 51 | — | — | 116 |
| Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired | 2 | 14 | 116 | — | 132 |
| Change in fair value of insurance-related derivatives and embedded derivatives | (34) | 8 | — | — | (26) |
| Change in fair value of market risk benefits | (12) | — | — | — | (12) |
| Operating expenses | 30 | 57 | 52 | 9 | 148 |
| Interest expense | — | — | — | 22 | 22 |
| Total benefits and expenses | 465 | 281 | 592 | 31 | 1,369 |
| Net income (loss) before income taxes | $150 | $(4) | $(47) | $20 | $119 |
| Six Months Ended June 30, 2024 | |||||
| Annuity | Life | Propertyand Casualty | Corporateand Other | Total | |
| (Dollars in millions) | |||||
| Revenues: | |||||
| Net premiums | $1,011 | $200 | $938 | $— | $2,149 |
| Other policy revenue | 105 | 191 | — | — | 296 |
| Net investment income | 1,035 | 187 | 80 | 70 | 1,372 |
| Investment related gains (losses) | 3 | — | — | (35) | (32) |
| Total revenues | 2,154 | 578 | 1,018 | 35 | 3,785 |
| Benefits, losses and expenses: | |||||
| Policyholder benefits and claims incurred | 1,084 | 326 | 706 | — | 2,116 |
| Interest sensitive contract benefits | 449 | 96 | — | — | 545 |
| Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired | 120 | 22 | 218 | — | 360 |
| Change in fair value of insurance-related derivatives and embedded derivatives | (12) | 14 | — | — | 2 |
| Change in fair value of market risk benefits | 158 | — | — | — | 158 |
| Operating expenses | 133 | 128 | 82 | 95 | 438 |
| Interest expense | — | — | — | 65 | 65 |
| Total benefits and expenses | 1,932 | 586 | 1,006 | 160 | 3,684 |
| Net income (loss) before income taxes | $222 | $(8) | $12 | $(125) | $101 |
| Six Months Ended June 30, 2023 | |||||
|---|---|---|---|---|---|
| Annuity | Life | Propertyand Casualty | Corporateand Other | Total | |
| (Dollars in millions) | |||||
| Revenues: | |||||
| Net premiums | $560 | $214 | $1,009 | $— | $1,783 |
| Other policy revenue | 17 | 183 | — | — | 200 |
| Net investment income | 382 | 161 | 90 | 33 | 666 |
| Investment related gains (losses) | — | — | — | (20) | (20) |
| Total revenues | 959 | 558 | 1,099 | 13 | 2,629 |
| Benefits, losses and expenses: | |||||
| Policyholder benefits and claims incurred | 594 | 305 | 790 | — | 1,689 |
| Interest sensitive contract benefits | 83 | 122 | — | — | 205 |
| Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired | 6 | 24 | 233 | — | 263 |
| Change in fair value of insurance-related derivatives and embedded derivatives | (53) | 53 | — | — | — |
| Change in fair value of market risk benefits | (7) | — | — | — | (7) |
| Operating expenses | 53 | 118 | 115 | 17 | 303 |
| Interest expense | — | — | — | 46 | 46 |
| Total benefits and expenses | 676 | 622 | 1,138 | 63 | 2,499 |
| Net income (loss) before income taxes | $283 | $(64) | $(39) | $(50) | $130 |
- Financial Commitments and Contingencies
Commitments
As of June 30, 2024, the Company had outstanding unfunded commitments to purchase, expand or improve real estate and to fund mortgage loans, private loans and investment funds of $3.3 billion.
In addition, the subsidiaries of the Company had outstanding letters of credit in the amount of $4 million as of June 30, 2024.
The Company’s subsidiaries lease office space, technological equipment and automobiles. The remaining long-term lease commitments as of June 30, 2024 were approximately $32 million and are included in the Company’s Statements of Financial Position within “Other liabilities”.
Federal Home Loan Bank (“FHLB”) Agreements
The Company has access to the FHLB’s financial services including advances that provide an attractive funding source for short-term borrowing and for access to other funding agreements. As of June 30, 2024, certain municipal bonds and collateralized mortgage obligations with a fair value of approximately $442 million and commercial mortgage loans of approximately $1.6 billion were on deposit with the FHLB as collateral for borrowing. As of June 30, 2024, the collateral provided borrowing capacity of approximately $1.5 billion. The deposited securities and commercial mortgage loans are included in the Consolidated Statements of Financial Position within “Available-for-sale fixed maturity securities” and “Mortgage loans on real estate”, respectively.
Litigation
Certain of the Company’s subsidiaries are defendants in various lawsuits concerning alleged breaches of contracts, various employment matters, allegedly deceptive insurance sales and marketing practices, and miscellaneous other causes of action arising in the ordinary course of operations. Certain lawsuits include claims for compensatory and punitive damages. We provide accruals for these items to the extent we deem the losses probable and reasonably estimable. After reviewing these matters with legal counsel, based upon information presently available, management is of the opinion that the ultimate resultant liability, if any, would not have a material adverse effect on the statements of financial position, liquidity or results of operations; however, assessing the eventual outcome of litigation necessarily involves forward-looking speculation as to judgments to be made by judges, juries and appellate courts in the future.
Such speculation warrants caution, as the frequency of large damage awards, which bear little or no relation to the economic damages incurred by plaintiffs in some jurisdictions, continues to create the potential for an unpredictable judgment in any given lawsuit. These lawsuits are in various stages of development, and future facts and circumstances could result in management changing its conclusions. It is possible that, if the defenses in these lawsuits are not successful, and the judgments are greater than management can anticipate, the resulting liability could have a material impact on the Company’s financial position, liquidity, or results of operations. With respect to the existing litigation, management currently believes that the possibility of a material judgment adverse to the Company is remote. Accruals for losses are established whenever they are probable and reasonably estimable. If no one estimate within the range of possible losses is more probable than any other, an accrual is recorded based on the lowest amount of the range.
- Subsequent Events
On July 29, 2024, the Board of Directors of the Company declared a cash dividend of $6.0 million on Series A Preferred Stock and $5.0 million on Series B Preferred Stock. The dividend will be payable on September 1, 2024 to shareholders of record as of August 16, 2024.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.